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Abstract 
High performance female athletes can jeopardize their health if their energy requirements 
during preparations for competitions are excessive.  The problems that result are called the 
Female Athlete Triad characterized by low energy availability with or without disordered eating, 
menstrual dysfunction/ amenorrhea, and osteoporosis and either alone or in combination can lead 
to more serious pathologies. The goal here is to determine whether intercollegiate female athletes 
exhibit elements of the triad at Western Washington University.  Sixteen athletes from Western 
Washington University’s soccer and cross-country program were recruited.  Participant’s 
average age was 19.24 years with an average height of 65.83 inches, average weight at 131.69 
lbs and 23.08% body fat and 21.43.   Each participant provided 72 hour dietary recall, and kept 
daily records on menstrual cycle changes and daily activities during and after the competitive 
season.     Body composition and bone density was assessed during and after the season.  Also 
collected daily, were urine samples for measures of estrogen, progesterone and cortisol (a stress 
marker).  None of the athletes suffered from all three components of the triad but fourteen were 
deficient in caloric intake and many were in macronutrient intakes (Deficiencies: sixteen for 
Vitamin D.; ten for calcium; thirteen in magnesium; nine in iron and all for potassium).  Caloric 
intake remained the same even during competition while expenditure differed significantly 
(p=0.05).  Estrogen and progesterone levels were lower but not pathologically lower during the 
competitive season.   
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Chapter 1 
 
Introduction and the Triad 
 
College athletic sports continue to rise in popularity and participation with a concurrent 
increase in the level of competitions (Kaestner & Xu, 2010; Troutman & Dufur, 2007).  
Likewise, the variety and participation of women collegiate sports is also growing.  The health 
benefit is for participating athletes are numerous and range from improving cardio vascular 
function and healthy weight maintenance to increased bone health and lower levels of stress 
(Blair, 2009; Janssen & LeBlanc, 2010), but there has also been an increase in the documentation 
of health risks, particularly disordered eating (Smolak et al., 2007; Sundgot-Borgen & Torstveit, 
2010), osteoporosis (MacLaren 2007; Pollok et al., 2010) and amenorrhea (Nichols et al., 2006; 
Warren & Chua 2008), which can create lifelong issues. The American College of Sports 
Medicine has termed the suite of these three disorders combined as the Female Athlete Triad 
(Rodrigues et al., 2009).   Increased participation in college sports may lead to increases in the 
prevalence of the triad, particularly for elite athletes who strive to compete at top levels (Reinken 
& Alexander 2005). Elite athletes may be training harder, facing more physical and emotional 
stress and possibly sacrificing their caloric and nutrient intake to fit a desired physique for their 
sport. The objective of this study is to monitor if this is the case and to what degree certain 
components of the triad are seen. 
Many female athletes who participate in sports such as swimming, gymnastics, dance, 
running and cycling have little body fat because they exercise strenuously and regularly; low 
body fat can have negative effects on their bodies (e.g. Dale et al., 1979; Frisch et al., 1987; 
Laughlin & Yen 1996; 1997; Nagai et al., 2010; Zanker & Swain, 2007).  De Souza and 
Williams (2004, 2005) report that excessive caloric expenditure from strenuous exercise
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 combined with poor eating habit is can lead to physiological changes including low levels of the 
female hormone estrogen.  Excessively low levels of estrogen can lead to prolonged loss of 
menses (amenorrhea) and demineralization of bone.   Amenorrhea is defined as the absence of 
three to six consecutive menstrual cycles in women of reproductive age; infrequent or irregular 
cycles is oligomenorrhea (Yeager et al., 1993).  Elite athletes are at increased risk for both 
conditions.  The incidence of amenorrhea varies depending on the sport due to the differences in 
physical activity and degree of competition.  De Souza et al, (2009) estimate that nearly half of 
all female athletes suffer from menstrual disturbance including amenorrhea, and amenorrhic 
athletes are at a higher risk for stress fractures, bone demineralization, and musculoskeletal 
injuries.  
The female athlete triad is a more severe condition characterized by poor 
nutrition/negative caloric balance, amenorrhea, and osteoporosis/osteopenia (Loucks, 2007; 
Torstveit et al., 2005 A).  Torstveit and Sundgot-Borgen B (2005) surveyed 669 female athletes 
about these symptoms and found that 70.1% of athletes with low levels of body fat displayed one 
or more components of the triad, while 5.4- 26.9% of female athletes reported at least two 
components.  It is likely that the lean sport athletes (swimming, running, cycling etc.) may be at 
an even greater risk of the components of the triad, especially with regard to energy flux, because 
of less energy storage in the form of fats as opposed to non lean sports (soccer, basketball, 
volleyball etc.).  
Energy flux is defined as elevated metabolic energy turnover through intake or 
expenditures under conditions of energy balance (Rarick et al., 2007).  Jasienska (2001) and 
Ellison (2003) argue that increased energy flux negatively influences reproductive function even 
when the energetic demands of competition are met by increased caloric intake and that there 
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may be an issue with ability to process the calories needed (Jasienska, 2001; Ellison, 2003).  This 
theory has been tested with other mammalian models i.e. rodents display a metabolic threshold 
which is reached under high energetic demands during which the body cannot compensate 
through increased food intake for the increased energy expenditure which is likely to be true with 
humans as well (Bacigalupe and Bozinovic, 2002).  There is a minimum amount of caloric 
energy that must be available in a woman’s body in order to maintain ovarian cycling (Frisch, 
1987; Ellison, 2001).  Insufficient energy availability (low caloric balance) means that some 
physiological functions must take precedence over others.   
Frisch (1987; 1996) and Vigersky et al. (1977) first claimed that reproductive functions 
could be disrupted by weight loss and require a minimum level of adiposity to trigger the onset 
and for maintenance of the menstrual cycle.  These claims have also been supported in more 
research (Ellison 2008; Thune et al., 2008).  Williams et al. (2001) found that exercise-induced 
low energy availability resulted in reduced hormone output and reproductive suppression without 
weight loss in a longitudinal study in female cynomolgus monkeys (Macaca fascicularis).   
Thus, Warren and Perlroth (2001) suggest that low caloric availability reduces reproductive 
function and this may be why reproduction is suppressed during intense exercise.   
Reproductive suppression in the face of high energy expenditures and poor diet is an 
adaptive strategy (Ellison, 2001; 2003) because women with low fat reserves should postpone 
pregnancy until food is more plentiful.  Low fat reserves due to exercise and sports training, even 
with sufficient caloric intake, can inhibit the menstrual cycle.  Initiation of training causes a 
sudden disruption to caloric balance with greater demands by the body for energy.  This shift can 
change the balance of reproductive hormones and lead to menstrual dysfunction (Ziomkiewicz et 
al., 2008).  Thus, intense physical exercise can alter reproductive function through one or both of 
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the physiological mechanisms (sudden high energy output and/or constant negative caloric 
balance) associated with negative caloric energy flux and lower levels of reproductive hormones. 
These may be two adaptive mechanisms to caloric stress that are activated when the body is 
being faced with low caloric availability in an effort to increase chance of future reproductive 
efforts.  
Ellison (2003) and Vitzhum et al.,  (2008) describe a “life history theory” postulating that 
there is a low energetic cost to terminating a current reproductive opportunity that has little 
chance of surviving to reproductive maturity.  This is done in an effort to increase an individual’s 
chances for successful procreation at a later time with more favorable conditions.   However, this 
model may not be the best theory to explain the driving mechanisms behind female athletes in 
the United States.  Vitzhum et al. (2009) contrasts two ways humans adapt to stressors.  They 
suggests that women in hostile settings are not going to respond to slight changes in caloric 
availability because things are likely to get better in their lifetimes.  They are less sensitive to 
changes than are women born into nutritionally rich settings.  The women living in rich caloric 
settings may be much more susceptible to caloric changes because it is likely that optimal 
conditions will soon return.  U.S. athletes fall into the optimal conditions category, where caloric 
availability is not an issue (Vitzthum, 2008).  This may explain some of the cessation and return 
to menses with initiation of sport.  However, in these situations (where calories are available) it 
may also be psychosocial stress factors i.e. meeting a desired body type or fitness level, team 
dynamic etc. that are the driving mechanisms behind low hormonal output and down regulation 
of the menstrual cycle. 
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Purpose of Study 
The female athlete triad (negative caloric balance, amenorrhea, and osteoporosis) reflects 
systemic responses to consistently high levels of activity coupled with possible poor food 
choices and has potentially serious negative impacts on reproductive function and bone mineral 
density (Nattiv et al., 1994, 2007; Yeager et al., 1993).  According to the American College of 
Sports and Medicine (2010), all physically active women and especially elite athletes may be at 
risk of developing the triad or varying degrees of the components of the triad which has been 
shown in many studies i.e. (Beals & Manore 2002; Hopkinson & Lock 2004; Loucks & Nattive, 
2005; Nattive et al., 2007; Reinking & Alexander, 2005; Spencer et al., 2008). The presence and 
extent of elements of the triad should be assessed even if the triad is not fully expressed because 
the long term health detriments are still yet unknown and athletes should be made aware of its 
effects and possible preventative measures (Okamoto et al 2010; Vescovi et al., 2008; Warren & 
Chua 2008).   Furthermore, the prevalence of these disorders varies depending on sport type and 
the level of athletic competition, with elite athletes being at highest risk (Goossen et al., 2008; 
Hoch et al., 2009).  Sundgot-Borgen and Torstveit (2007) monitored female football (soccer) 
players and endurance athletes and found that 24% of the football/soccer players and 44% of the 
endurance athletes were diagnosed with an eating disorder.  Smolak et al., 2000 argue that 
upwards of sixty two percent of female athletes may suffer from disordered eating.  Thus, the 
degree of vulnerability to the components of the triad varies depending on nutritional choices, 
the specific sport and the level of competition.  Preventative measures and education must be 
adjusted accordingly, including the contribution of other possible stress factors which can 
exacerbate or help trigger the development of the triad. 
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The purpose of this study is to examine female collegiate athletes for energetic, 
reproductive and stress related factors that may contribute to the onset of the female athlete triad.  
Markers of stress will also be evaluated for their effect on reproduction in this population to see 
if there is a situational difference (physical vs. psychosocial) that has a greater negative effect 
over another i.e. caloric deficiency, training, competition.  Female soccer and cross country 
athletes were monitored and compared to one another for the duration of one competitive season 
to see if there is variation due to sport type.  The specific biomarkers monitored were urinary 
levels of cortisol for a stress marker, and metabolites of estrogen and progesterone (estrone 
conjugate (E1C) and progesterone pregnanadiol 3-glucuronide (PdG)), because of their role in 
reproduction and overall health as well as their many interactions on the various components of 
the triad.  Dietary and anthropomorphic analyses were also taken to look at overall caloric and 
mass change when comparing season to post season values.  This study was also meant to be a 
pre-curser to several follow up studies of the same nature.  The follow up studies would provide 
a much larger subject data pool with the overall intent to monitor athletes from the beginning of 
their athletic career until graduation from WWU.  Furthermore, data samples were kept in order 
to re-analyzed with the thought that they would be used to look at levels of other hormone 
markers such as follicular stimulating hormone, growth hormone, luteinizing hormone and 
insulin-like growth factors and binding proteins when funding became available. 
It is hypothesized that the female athletes are under much greater caloric energy 
expenditures during the competitive season and must consume more calories to compensate, or 
they will begin to show signs of the triad.  Those who do not eat additional calories to offset their 
increased energetic needs will also likely show deficiencies in key nutrients such as calcium and 
potassium.  I also believe that levels of cortisol will be much higher during the season due to 
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stress of the accelerated training and competition.  The increased cortisol levels may lead to 
decreased reproductive hormone production.  Each of these hypotheses will be addressed in the 
following chapters as they relate to the female athlete triad.  Chapter 2 examines the physiology 
of reproduction and stress along with the markers used in this study to look at the mechanisms 
underlying the components of the female athlete triad.  Chapter 3 reviews the interactions 
between stress and reproduction with it is relation to the triad. Chapter 4 describes sample 
selection and methods.  Chapters 5 and 6 are results, discussion and conclusions, respectively. 
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Chapter Two 
Markers of the Menstrual Cycle and Stress 
 
Estrogen, Progesterone and Menstruation 
The female reproductive cycle is under the control of gonadotropin-releasing hormone 
(GnRH), which is a neurohormone secreted from the hypothalamus and several other hormones 
including the protein hormones luteinizing hormone (LH) and follicular stimulating hormone 
(FSH), which are released from the anterior pituitary gland, and the ovarian steroids estrogen and 
progesterone (Holes 2002).  The concentrations of these hormones roughly follow a twenty-eight 
day cycle.  The cycle follows a pattern from menstruation to follicular development, ovulation 
and if not fertilized, back to menstruation.  The complete cycle relative to hormone 
concentrations and day of ovarian cycle is presented in Figure. 1.   
The ovarian cycle begins at the first day of menstruation (Griffin & Ojeda, 1996; 
Silverthorn, 2009).  The initial segment of the ovarian cycle is termed the follicular phase.  
During this phase gonadotropin-releasing hormone (GnRH) stimulates the release of follicular 
stimulating hormone (FSH) from the anterior pituitary gland which stimulates the release of 
estrogen, and progesterone from the ovaries. The presence of FSH also provides negative 
feedback for GnRH production.  In turn, estrogen exerts negative feedback on FSH to prevent 
the development of additional follicles while prompting estrogen production by the already 
present follicles.  These remaining follicles grow in size as their granulosa cells – specialized 
secretory cells that form a single layer around the ovary – continue to secrete hormones and 
enzymes into the antrum, which is a fluid filled cavity within the follicle of the ovary, facilitating 
ovulation (Silverthorn, 2009).   
9 
 
 
Figure 1: Hormonal Profile of the Female Menstrual Cycle, upload.wikimedia.org 
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This phase is also accompanied by an increase in blood flow, more oxygen and nutrients to the 
thickening endometrium of the uterus.  The late follicular phase is marked by peak levels of 
estrogen secretion.  At this stage, the granulosa cells of the follicle begin to secrete the hormones 
inhibin and progesterone.  Estrogen then activates a surge of luteinizing hormone that signals the 
body to begin the second stage of ovulation (Wood, 1994). 
The surge of LH signals the release of the egg as well as the conversion of the follicle 
into a corpus luteum.  The corpus luteum is responsible for the production of progesterone and is 
involved in readying the endometrium for possible implantation of an egg (Wood, 1994).    
Estrogen continues to prepare the uterus for the possibility of pregnancy by stimulating 
endometrial growth. Once LH peaks, there is a latent period of around twenty hours, followed by 
ovulation.  At this stage, collagenase is released to dissolve the connective tissue holding the 
follicular cells together.  The egg is then released and carried to the fallopian tube to be 
fertilized.  With the ejection of the egg, the follicle regresses and becomes a specialized gland 
known as the corpus luteum, which begins the luteal phase (Wood, 1994). 
Production of estrogen and progesterone from the corpus luteum steadily increases during 
this stage (Silverthorn, 2009).  Both inhibit follicular development by inhibiting the 
hypothalamus from secreting GnRH and the anterior pituitary from secreting FSH and LH.  
Progesterone further drives the development of the endometrium of the uterus.  The cells of the 
endometrium deposit lipids and glycogen into their cytoplasms which will be used as 
nourishment for the developing embryo.  Progesterone also causes the cervical mucus to thicken 
and form a plug to prevent bacterial invasion.  The luteal phase lasts approximately twelve days, 
after which the luteum will spontaneously undergo apoptosis unless fertilization of the egg 
occurs (Silverthorn, 2009).  At this point, levels of progesterone and estrogen decrease, which no 
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longer inhibit is the pituitary and hypothalamus glands, and FSH and LH production resumes.  In 
the absence of progesterone’s stimulus to maintain blood supply, the corpus luteum degenerates 
and blood vessels in the surface of the endometrial layer contract.  The absence of vessels and 
their supply of oxygen and nutrients lead to cell necrosis and the beginning of menstruation 
(Silverthorn, 2004).   
The relationship between metabolic demand and reproduction are not fully understood in 
female athletes (De Souza and Williams, 2006; De Souza et al., 2004; Ellison, 2005; Harshman 
& Zera, 2006; Loucks, 2005).   It is believed that the link between energy availability and 
reproductive function involves the interactions of metabolic hormones and the reproductive axis. 
To further complicate this relationship, the release of stress hormones such as cortisol via 
activation of the stress axis introduces another confounding variable by inhibiting reproductive 
hormone release.  
 
Cortisol and the Physiology of Stress 
Stress is defined as a disruption of the normal homeostatic state of the body 
(Charmandari et al., 2005).  Types of stressors to the body include metabolic, psychosocial, 
physical or a combination of these (Cacioppo, 2005).   The body reacts to stress through the 
central and peripheral nervous systems, initiating complex physiological and behavioral 
responses to counter disturbances, whether they are real or perceived threats.  These responses 
are mediated through the release of several hormones, including cortisol, epinephrine and 
norepinephrine. Stress can lead to illness, degradation of reproductive function and physical 
breakdown of the body (Baum, 1999; Gunnar & Quevedo 2007; Sasiene, 1983).   
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 Psychosocial stress is believed to contribute to the triad and may be the initial triggering 
factor that contributes to poor eating habit is (Jacobson et al., 2009; King et al., 2009; Sauro et 
al., 2008).  The stress to fit in and or physically meet a generalized stereotype for a given sport 
induces many female athletes to make poor dietary choices in an effort to lose weight.  
Emotional stress can also cause a loss of appetite and limit food consumption. Serious cases can 
even develop into bulimia and/or anorexia nervosa.  Mental stress and constantly worrying about 
daily interactions, games, school etc. can disrupt sleeping cycles and rob the body of important 
rest periods during which the body recuperates and rebuilds. 
Stress can be acute, exerting it is effects over short periods of time, or chronic, in which 
the effects persist for days, months or years (Sherwood, 2007).  Prolonged, repetitive acute stress 
can be considered as a form of chronic stress.  Persons experiencing chronic stress may also have 
a heightened response to acute stress (Pike et al., 1997).  There are various responses to acute 
stress that facilitate the fight or flight response in order to prevent harm to the organism 
(Silverthorn, 2009).  The sympathetic nervous system reacts by readying the body to respond 
quickly to metabolic changes caused by intense activity. Physical responses include vasodilation 
of vessels supplying blood and oxygen to skeletal muscle, increased respiratory and 
cardiovascular rates, and increased energy use.  Vasoconstriction also occurs in areas of the body 
such as the digestive, immune and reproductive systems, which are not utilized in a fight or flight 
response in order to conserve energy.  Behavioral responses include heightened awareness, 
increased cognition, focused attention and inhibition of vegetative functions such as appetite 
(Charmandari, 2005).  These responses lead to increased muscular function and heightened 
awareness. 
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The response to stress is complex and affects many of the body’s systems 
(cardiovascular, digestive, muscular, etc.) depending on the types of stressors involved 
(Charmandari, 2005).  Metabolic, psychosocial and physical stressors activate the hypothalamic-
pituitary-adrenal axis (HPA), bringing about the release of cortisol from the adrenal cortex and 
system-wide physical changes. More specifically, the release of corticotrophin-releasing 
hormone (CRH) from the hypothalamus in response to stress stimulates the release of 
adrenocorticotropin hormone (ACTH) from the anterior pituitary gland.  ACTH then acts upon 
the adrenal cortex to release glucocorticoids such as cortisol and hydrocortisone.  
Glucocorticoids stimulate changes in gene transcription rates of target tissues (Sapolsky et al., 
2000; Nepomnaschy et al., 2007).  See Figure 2 for a diagram of the HPA axis.  A detailed 
account of the neural and endocrine pathways involved in the stress response is provided in 
Appendix A.   
Cortisol (hydrocortisone) is a steroid hormone that promotes gluconeogenesis, or the 
creation of new glucose by the liver which raises glucose levels in the blood (Holes, 2002).  
Cortisol also promotes lypolysis, which is the conversion of fat cells into metabolic energy.  The 
presence of cortisol in the blood helps to maintain blood glucose levels between meals for cell 
metabolism.  Cortisol follows a diurnal rhythm, peaking in early morning and decreasing before 
bed and can negatively affect the release of estrogen and progesterone, two key hormones in the 
female reproductive cycle (Chrousos et al., 1998). 
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Adapted from Silverthorn 2004 
 
 
Figure 2:  Hypothalamic-Pituitary Adrenal cortisol axis (flow diagram). 
HPA: Hypothalamic-Pituitary Axis 
CRH: Corticotropin Releasing Hormone 
ACTH: Adrenocorticotropic Hormone 
CNS: Central Nervous System 
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Chapter Three 
Stress and Reproduction     
 
Vitzthum (2003, 2008, 2009) proposed her flexible response model (FRM) to explain the 
surprising inconsistency between the easily disturbed, often suppressed reproduction of US 
women versus the highly fertile, malnourished women of developing regions who work long 
hours doing strenuous work.  In the US, women are gestated and born into optimal conditions 
and their bodies anticipate a ready return to optimal conditions.  Conversely, the bodies of 
women born to malnourished mothers do not expect that conditions will change and thus, there is 
no benefit to delaying reproduction.    
Under optimal conditions it is advantageous for the woman’s reproductive machinery to 
maintain ideal levels of support that when not present, are assumed to be likely to return soon 
(Vitzthum 2008). This sensitivity to local conditions may be triggered by energy deficiencies that 
activate a collection of counter-regulatory mechanisms involving various endocrine systems 
(Marcus et al., 1985; Myerson et al., 1991; Wade et al., 1996).  These mechanisms involve a 
complex interplay between the levels of cortisol, Adrenocorticotropic Hormone (ACTH), 
Leutinizing Hormone (LH), insulin-like growth factors (e.g. IGF-I), Glucocorticoids and other 
metabolic hormones involved in this counter-regulatory mechanism (Nepomnaschy et al., 2007). 
Laughlin & Yen (1997) found that cortisol levels rise proportionally to the body’s nutritional 
stress.  Reproductive function and metabolically derived alterations in cortisol may be part of the 
causal mechanism connecting energy availability and reproductive function (Ellison, 2001; 
Bereket et al., 1996; Katz et al., 1998).  The interactions of caloric insufficiency, rise in cortisol 
levels, and decreased production of reproductive hormones are presented in Figure 3. 
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The inability to “turn off” the heightened alert state caused by the activation of the stress 
axis is experienced as chronic stress, with continuously high levels of the stress hormone cortisol 
brought on by an increased secretion of corticotrophin releasing hormone (CRH) from the 
hypothalamus (Silverthorn, 2009).  Chronic stress has been linked to various poor health 
outcomes including high blood pressure, reduced immune function, cardiovascular disease, bone 
degradation, thyroid dysfunction, infertility and a range of emotional conditions including 
depression (Baum & Posluzny, 1999; Charmandari et al., 2005; Chrousos et al., 1998; 
Drinkwater et al., 1984; Chrousos et al., 2002; Jokinen & Nordstrom, 2008).   
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Adapted from Ellison 2001 
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caloric insufficiency 
 
counter 
regulatory 
mechanisms 
increased 
cortisol release 
Hypothalamus 
GnRH 
Anterior Pituitary 
LH FSH 
     - 
Ovaries 
Follicle 
Granulosa 
Cells 
Thecal 
Cells 
androgensprogesteroneinhibin 
high estrogen 
  - 
18 
 
Psychosocial and Physical Stress in the Female Athlete 
Psychosocial stress can be brought on by any acute negative emotional disturbance in 
which a person feels they are “threatened” or faced with failure, or are in an unfamiliar situation 
(Cacioppo, 2000).  Psychosocial stress activates both the sympathetic and the hypothalamic-
pituitary adrenocortical systems.  Flinn & England (2003); Flinn & Ward (2005) showed that 
cortisol levels in children rise in response to psychosocial stimulation of the stress axis and that 
these types of stressors give a greater response compared to physical stressors.  Elevated cortisol 
levels were correlated to compromised immune function and lowered mental health.  This work 
demonstrates that a single strong emotional occurrence may result in prolonged elevation of 
cortisol which can negatively affect health on a long term basis (Flinn, 2006; 2008).   The daily 
lives of college athletes are filled with perceived stressful events including varying social 
interactions, examinations, project due dates, and work related conflicts.  The repeated exposure 
to these everyday stressors, when combined with the time commitment, injuries, and competitive 
nature of collegiate sports may bring about chronic stress in some individuals (Shirom, 1986; 
Ross, 1999; Smith, 2001).   
Caperton et al., (2006) monitored a group of female baboons during an imposed stressful 
environmental change (caging an individual separately from the group) and noted a significant 
delay in the follicular stage of menstruation.  A longitudinal study of a rural Mayan community 
showed that elevated cortisol levels due to daily “life stressors” were also shown to increase 
levels of gonadatropin and progesterone, which can inhibit ovulatory and luetinization processes 
in the follicular phase of the menstrual cycle (Nepomnaschy et al., 2004). A similar study by 
Barzalai-Pesach et al., (2006) found similar results in decreased fertility with women and 
19 
 
perceived occupational stress. This suggests that there is a strong correlation between 
psychosocial stress and key components of menstrual function. 
Metabolic stress is a form of chronic stress that is best described as a shortage of energy.  
The metabolic stress response refers to the adjustments the body makes when chronic energy 
expenditure is not matched by intake (Ellison, 2001).  The extent of caloric shortfalls exists as a 
continuum from relatively mild to more extreme, i.e. starvation, with the response of the body 
being proportional to the degree of the imbalance (Smith, 2001).  Female athletes may be 
experiencing metabolic stress due to high levels of energy output associated with training and 
competition.  This stress may be further affected by inadequate consumption of calories.  The 
body responds to this stress through the release of cortisol which acts to mobilize fat stores and 
initiates gluconeogenesis to create free glucose for immediate energy use (Sherwood, 2007).  
The amount of cortisol released depends on the energy requirements of the body.  A state of 
constant caloric deficiency will lead to chronically elevated levels of cortisol in the body. 
Physical stress can be acute or chronic and is caused by physical disturbances such as 
burns, sepsis, surgery and trauma (Groff et al., 1996).  For competitive athletes, some additional 
stressors may include muscle fatigue, injury, inflammation, pain, and the processes involved in 
repairing these conditions.  Although athletes suffer from these stressors on a regular basis, it is 
hard to assess the effects of these conditions.  For this reason physical stressors will not be 
considered separately from metabolic and psychosocial stress in the current research. 
Parnabas and Mahamood (2010) evaluated levels of anxiety before and during 
competitions and found that individuals reported a rise in anxiety levels just prior to competition.  
Additionally, plasma levels of cortisol increased both before and after races.  Kuo et al., (2006) 
also found that overall cortisol levels increased more during competition than during regular 
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training in female volleyball players.  They argue that the increased training and strain of 
competition can create a metabolically and psychosocially stressful situation in which the HPA is 
activated and maintained for prolonged periods rather than subsiding within a day of the 
competition.  Similarly, Aizawa et al., (2006) noted that there was a significant increase in 
cortisol and leutenizing hormone (LH) levels, accompanied by an increase in mood-fatigue 
scores in elite female soccer players after three days of competition.  They also suggest that the 
hormonal changes reflect both mental and physical stresses of competition.  Infrequent acute 
stress has many advantages for the body such as mobilization of glucose stores, increased 
cardiovascular and respiratory function and increased cognitive awareness (Silverthorn, 2009).  
These changes help the body to reach optimal potential in order to deal with threatening 
situations.  The “fight or flight” response is the most commonly used description for the 
occurrences of the stress response, which readies the body to either run from danger or stand and 
face the situation.  A repeated exposure to acute stress can be viewed as a type of chronic stress 
and can lead to illness (Flinn, 2008).  In the case of female athletes, prolonged stress not only has 
implications for long term health but can also cause short term health problems such as immune 
and reproductive dysfunction.  These levels of stress can be monitored using cortisol for a proxy.   
Chronic activation of the HPA during stress can cause a disruption of the reproductive 
system.  The discharge of corticotropin releasing hormone (CRH) from the hypothalamic-
pituitary adrenal axis can inhibit the reproductive axis at many levels (Charmandari, 2005). 
Chrousos et al. (1998) showed that CRH is responsible for inhibiting GnRH  release from the 
hypothalamus, and glucocorticoid release such as cortisol inhibit is LH, estrogen and 
progesterone release.  Breen et al. (2007) used a sheep model to demonstrate that cortisol 
significantly suppresses the release of luteinizing hormone through mediation of a type II 
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glucocorticoid receptor, thus reducing pituitary responsiveness to GnRH.  Furthermore, this 
interference with follicular development can delay or block the preovulatory LH and FSH surges.  
Kalantaridou et al. (2004) found that CRH inhibit is ovarian estrogen and progesterone release 
through it is inflammatory interaction within the ovary.  A comprehensive review of the 
endocrinology of the stress response can be found by Charmandare et al. (2005).  
 
Summary and Hypotheses 
The ovarian cycle is susceptible to both psychosocial and metabolic stress (Sherwood, 
2007; Charmandari et al., 2005).  Cortisol levels are elevated during periods of low energy 
availability, whether brought on by limited caloric intake, increased activity, or a combination of 
the two (Bouget et al., 2006; Klein et al., 2007; Laughlin &Yen, 1996; 1997; Straub et al., 2008; 
Uusitalo, 1989).  This makes it difficult to tease apart psychosocial stress from low metabolic 
energy availability when measuring cortisol levels and discussing the possible causal role of 
cortisol in the suppression of the reproductive system.  Sasiene (1983) showed that female 
athletes experiencing secondary amenorrhea were usually under a combination of psychosocial 
and metabolic stressors from training as well as weight loss.  Others have noted that elevated 
cortisol levels during the stress from training, dieting and the resulting decreases in body fat 
stores disrupt normal levels of reproductive hormones and that female athletes engaging in these 
activities are at higher risk for oligomenorrhoea and amenorrhea (Arena et al., 1995; Breen et al., 
2007; De Souza and Williams 2004, 2005; Kalantaridou et al., 2004; Laughlin & Yen, 1996).  
Still this begs the question of what are the relative contributions of the various stressors with 
respect to reproductive suppression  
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Hypotheses 
Overall Model:  Female college athletes will be in a state of lowered energy availability during 
the competitive season due to training and participation in their sport.  During this time we 
should see increased levels of cortisol and decreased levels of estrogen and progesterone as it 
should portray a somewhat chronic level of increased stress.  Furthermore, we should see peaked 
levels of cortisol during acute stressful events such as competitions.  This will not be the case 
during the off-season, where we should see lower levels of daily cortisol concentrations and 
increased levels of estrogen and progesterone production.   
 
Testable Implications 
 Overall body weight and percent body fat will decrease from the start of the season until 
completion of season.  Athletes who do not compensate expenditure with increased 
caloric and proper nutrient intake are expected to suffer from inadequate levels of 
important nutrients such as calcium and potassium.  
 
 Reproductive hormonal output will be lower during the competitive season due to low 
energy availability and/or increased energy output and increased levels of stress.  
Hormonal levels will recover after completion of the season as training tapers off and 
competition ceases. 
 
 Levels of systemic cortisol will increase with stress during the competitive season and 
decrease after completion of the season.  
 
 Cortisol levels will be negatively correlated to reproductive hormones. 
 
 Overall reproductive hormone profiles during training will resemble those found in 
women of traditional populations with high energy output. 
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Chapter Four 
Methods 
 
 The design for the study provides a natural, longitudinal scenario with the future intent of 
re-running the study several times with larger sample sizes and repeated season measures.  
Sixteen female athletes were recruited from Western Washington University’s soccer and cross 
country programs.  The average age for our sample was 19.24 years old with a standard deviation 
of 1.46 years.  Average height of individuals in this study was 65.83 inches with a standard 
deviation of 2.69 inches.  The IS values for average weight, percent body fat and BMI were 
131.69 lbs. (SD= 13.86), 23.08% body fat (SD= 3.83) and a BMI of 21.43 (SD= 1.83).  Off 
Season values were recorded three weeks or more after training and competition had ceased.  
The average values for OS were 130.85 lbs. (SD= 14.13), 20.93 percent body fat (SD= 3.06), and 
a BMI of 21.12 (SD= 3.88).   
Subject # Age Height Weight 1 BMI 1 BD/ Sfiff. Index % Body Fat 1 Weight 2 BMI 2 % Body Fat 2
1001 18 67 1/2 147 22.68 122 ± 2 25.5 143.7 22.17 21.2
1002 19 67 1/4 155.7 24.20 145 ± 2 26.7 157.6 24.50 26.3
1004 19 66 1/8 152.9 24.58 159 ± 2 28.2 149.1 23.97 26
1005 18 62 131.5 24.05 96 ± 2 20.7 130.3 23.83 22
1006 19 68 3/4 131.6 19.57 108 ± 2 19.3 131.4 19.54 21.4
1008 22 63 123.1 21.80 194 ± 2 20.7 120.8 21.40 18.9
1009 19 69 1/8 147.8 21.75 136 ± 2 25.6 149.2 21.95 23.1
1010 21 67 1/2 132 20.37 119 ± 2 18.4 131.7 20.32 22.9
1011 19 65 114.5 19.05 112 ± 2 19
1012 20 66 145 23.40 23 143.5 23.16 26.2
1013 18 65 136.3 22.68 141 ± 2 27.4 136.9 22.78 29.2
1014 20 62 110.1 20.14 137 ± 2 19.7 109.4 20.01 18.5
1015 21 63 1/8 116.6 20.57 129 ± 2 19.2 118.7 20.94 22
1017 19 66 1/2 117.7 18.71 144 ± 2 14.3 115.3 18.33 13.7
1018 18 63 1/4 118 20.74 129 ± 2 21.2 118.7 20.86 23.3
1019 18 70 1/2 124.5 17.61 131 ± 2 16.6 125.5 17.75 20.8
1020 19 66 126.4 20.40 116 ± 2 24.3 128.5 20.74 26
Table 1:  Participant discriptive data for in season and post season values of anthropomorphic measures
Season Values Post Season Values
 
 
24 
 
The head coach of each team was contacted and informed of the study proposal and 
asked to present the project to the team and promote participation.  Those interested in the initial 
proposal were then given a formal introduction to the study and encouraged to apply.  
Participants received university credit for their participation.  They were screened for health 
problems and completed the Beck Depression Inventory and the Garner Eating Disorder 
Inventory to assess mental health status and eating disorder risks.  All subjects passed screening 
and none were excluded from the study.  Medical histories, menstrual cycling histories and 
contraceptive usage was also gathered.  Written consent was obtained and the benefit is and risks 
of participation were fully explained to each subject. All participants completed a full physical 
examination prior to participating as part of their requirements for participation in University 
athletics.  If eating disorders, the potential to develop an eating disorder, or other physical 
complications were discovered, they would have been directed to the appropriate on-campus 
health provider and also excluded from the study. 
For this study, we wanted to determine what the overall daily caloric intake and 
expenditure looked like for each individual so we could determine the overall caloric balance.  
Daily dietary journals that record  types and amounts of food, as well as energy expenditures 
derived from the types and amounts of activities, have been used to determine overall metabolic 
standing in previous studies (Laughlin, 1996 not in refs sited; Caregaro, 2001; Day et al., 2001). 
Crawford et al. (1994) showed that dietary recalls are most informative between three and four 
days and information and conclusiveness begin to fall off as a subject approaches a full seven 
day journal.   
We followed methods developed by Caregaro (2001).  Daily energy expenditures and 
intakes were estimated based on 72 hour records of self-reported dietary intakes and activity 
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patterns during competition, and after the season concluded.  Dietary recall methodology was 
used, in which each subject was asked to personally record and keep track of their dietary 
information in a dietary journal.  Each subject was instructed on how to keep track of their 
dietary information as well as given verbal and written information to help them determine 
portion sizes.      Each subject’s dietary journal was analyzed solely by the author to maintain 
consistency of data input such as deciding portions size, activity level, and durations when none 
were specifically given.  Dietary Analysis 8 nutritional analysis software was used to measure 
estimated daily energy intake and expenditures from the data gathered by participants.    
Body composition was assessed once at the initiation of the study and again at the end of 
the study by air plethysmography through BOD POD analysis.  The BOD POD is a body 
composition measuring unit that was developed by Life Measurement Inc (LMI).  Body 
composition is calculated through air displacement of the human body, much like previous 
methods with water displacement in underwater weighing.  The accuracy of the BOD POD is 
equal to that of water displacement methods (Fields et al, 2005; Miyatake et al, 2005; Frisard et 
al, 2005). BOD POD is compared to other methods at the LMI website (www.bodpod.com, 
2006).  Each subject was instructed to take very specific steps for preparation before being 
analyzed, which followed the protocol set forth by LMI.  The measuring apparatus is very 
sensitive and subtle changes in temperature and surface area can affect the measures.  For this 
reason it was important that both trials occur in similar settings.  Participants were instructed to 
avoid eating, drinking or exercising three hours before being measured in an effort to control for 
overall body temperature.  The machine functions through air displacement, which requires that 
participants shave excess hair and wear Lycra swimsuit is to minimize extra surface area that 
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might affect airflow through the machine.  They were also instructed to wear the same swimsuit 
when analyzed for the second body composition measurement.   
 Bone density scanning was completed through Mt. Baker Imaging’s women’s health 
division.  Heel bone densities were assessed with the Achilles Insight Bone unit.  The density of 
the calcaneus bone in the foot was measured through ultrasound.  The scans were performed in a 
clinic by a trained professional.  The results are presented as a stiffness index for each individual.  
The stiffness index is reported as a whole number and indicates the risk of osteoporotic fracture 
as compared to overall bone density.  A T-score is also reported to show the range in which the 
individual’s stiffness index falls relative to other individuals.  The T-score can be further 
converted to an individual Z-score representing how many standard deviations the individual’s 
index is relative to the average index of healthy young adults of the same sex and age. This 
number is then compared to known values of bone mineral densities calculated through X-ray 
absorptiometry of the hip or spine.  Low t-scores (0 to -1) are considered healthy, more negative 
scores (-1 to -2.5) reflect osteopenia and even lower scores (>-2.5) represent osteoporosis 
(Achilles Operator’s Manual, nd).  The Achilles ultrasound heel density unit is a well established 
indicator of overall bone health (Greenspan et al., 1997; Rosen & McClung, 1998; Thompson et 
al., 1998).  The indices derived from ultrasound densitometry are also strongly, positively 
correlated with measures from dual energy x-ray absorptiometry (DEXA) which is the clinical 
standard for measuring osteoporotic conditions (Huang et al., 1998; Bauer et al., 1997). 
 The athletic seasons started in August and sampling began the first week of the fall 
quarter in September.  Thus participants were at an increased level of energy expenditure at the 
start of data collection.  Participants were instructed on the usage of a hand held, sponge 
collection and storage container for urine sampling.  The first morning urine samples were 
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collected daily through the 10 week study to monitor levels of cortisol as well as metabolites of 
estrogen and progesterone; estrone conjugates (E1C) and pregnanediol 3-glucuronide (PDG).  
Samples were immediately frozen and stored at the participants’ home for two weeks and then 
transported frozen in coolers to the WWU Biodemography Laboratory where they were stored 
until processing.  Urinary assays were chosen for a variety of reasons, including affordability.  
Sample collection was much easier using urine rather than blood for our study.  Human subject’s 
approval was much easier with the urine collection as it is much less invasive/harmful, far more 
sterile, and athletes were more accepting of collection means as compared to blood samples.  
Urine also provided a much more stable and easy to handle substrate when it came to the teams 
traveling out of state for competitions.  The samples were able to be frozen and shipped via one-
day freight in provided Styrofoam cooler boxes.  Reproductive hormone metabolites have also 
been shown to be in higher concentrations than that of circulating serum concentrations, possibly 
providing better analysis markers for athletes suffering from decreased levels of hormone 
production.  The specific immunoassays used in this study were developed at the University of 
Washington and were proven in several field tests.  All urinary hormone levels for these specific 
assays were significantly correlated (E1C, r =0.93; PDG, r= 0.96; Cortisol, r = 0.97) with levels 
found in circulating serum (Neary et al., 2002; O’Conner et al., 2003; 2004). 
To process, each sample was thawed by incubation at room temperature for two hours 
and was then placed in a refrigerator and allowed to completely thaw over the next twenty-four 
hours.  The samples were then attached to permanent collection vials that would hold the urine 
after centrifuging it out of the sponges.  Each sample was spun at 2,500 rpm for a total of two 
minutes.  The intermediate vials for holding the sponges while centrifuging were immediately 
washed and thoroughly rinsed with both regular and then de-ionized water, dried and then 
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reused.  All sponges for sampling were only administered one time and then thrown away to 
avoid any cross contamination.  The centrifuged samples were labeled and refrozen until 
assayed. 
 
Assay Reagents and Protocols 
A microtiter plate-based, enzyme immunoassay (EIA) was used to determine urinary 
concentrations of estrone-3-glucuronide conjugates (E1C), pregnanediol glucuronide (PdG) and 
cortisol.  These EIAs where purchased from the University of Washington’s Center for Studies 
in Demography and Ecology and the methods used follow as described by O’Connor et al. 
(2003; 2004).  Personal communications with Eleanor Brindle (Director of the CSDE 
Biodemography Core at the University of Washington) proceeded throughout the study to assure 
proper assay procedures. The E1C EIA calls for a 155B3 monoclonal antibody which has a 
100% cross-reactivity with the free estrogen conjugates estrone, estrone sulfate and estrone 
glucuronide (Kohen & Lichter 1986).  Detailed descriptions of the assay can be found in the 
article describing it is development (O’Connor et al., 2003). The monoclonal antibody for the 
PdG EIA is Quidel 330.  The Quidel 330 antibody works by cross reacting with PdG and 20-
alpha-hydroxy-4-pregnen-3-one (O’Connor et al., 2003).  The limit is of detection (mean +3 SE 
above standard) for the E1C EIA are 0.27 nmol/L and 0.21 nmol/L for the PdG EIA, with inter 
and intra-assay variance of 10% and 10% for the E1C EIA and 8% and 13% for the PdG EIA.  
Cortisol assays were plated using R4866 Cort-Pab antibodies.  Urine specimens were assayed in 
duplicate, and were added to the assays neat, or prediluted for higher concentration specimens.  
Absorbance was measured with a Bio-Tek Elx808 plate reader (test wavelength 405 nm, 
reference wavelength 620 nm).  Boi-Tek’s KC4 v3.0 Bio-Tek microplate analysis software was 
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used to analyze hormonal concentrations through optical density readings using a four parameter 
logistic model (BIO-TEK Instruments, Inc. Winooski, Vermont).  The full description of assay 
protocols for E1C, PDG, and Cortisol for this study is provided in appendix H. 
 Normalization of hormone concentrations was taken through specific gravity, by 
correction for raw hormone concentrations follows such that xraw as : xcorrected=xraw(SpGtarget-
1)/(SpGsample-1), where SpGsample is the specific gravity of the specimen, and SpGtarget is a target 
specific gravity (O’Connor et al. 2003).  We used a target specific gravity of 1.020 as suggested 
in the literature (Goldberger et al., 1995; Holman et al., 2006; O’Connor et al., 2003).  Specific 
gravity measurements were taken with a hand held urine specific gravity refractometer (ATAGO 
U.S.A., Inc.)  Specific gravity was used for correction rather than creatinine excretions due to the 
fact that reproductive status can significantly affect the amounts of creatinine excreted in urine 
(Holman, 1996).  The E1C predict model from the University of Washington’s CSDE lab was 
used to further correct E1C values and were done to account for the effects of variation in 
dilution on 3F11. 
 The presence of menses, timing of ovulation, and overall quality of ovulatory cycles, are 
variables that can be addressed in the current study.  Daily records were kept denoting day of 
menstrual cycle and if the subject was mensing or not.  Detection of ovulation was achieved by 
analyzing urinary reproductive hormones collected daily by calculating the shift from follicular 
estrogen to luteal progesterone (Baird et al., 1995).  Further information on methods of ovulatory 
detection can be found in Appendix B. 
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Analyses 
All participants’ hormone values were adjusted to menstrual day using participants self-
reports of menses.  SPSS statistical analysis software (OEM Technologies) and Excel (Microsoft, 
Corp.) provided statistical comparison analyses.  One-way ANOVA with repeated measures for 
“contraception use” as the between groups variable was used to assess the effects of oral 
contraceptive use on hormonal profiles. One-way ANOVA with repeated measures with “sport” 
as the between groups variable was used to assess the effects of type of sport (soccer or cross-
country) on hormonal profiles. Unless otherwise noted, participants were separated into 
contracepting and non-contracepting groups for all subsequent statistical analysis.  Data was 
analyzed using two-way ANOVA with repeated measures design for “menstrual day” and 
“season” as the within group variables.  Delta-values were calculated for all hormones by 
subtracting off-season (OS) from in-season (IS) values and one-way ANOVA with repeated 
measures design using “menstrual day” as the within group variable was used to search for 
menstrual day effects on differences in hormonal values. Time bins were created to summarize 
data by finding the average values of each bin for each subject during the follicular (menstrual 
days 2-9), ovulatory (menstrual days 12-19) and the luteal (menstrual days 21-28) portions of the 
ovarian cycle. Post-hoc comparisons were done with the least squared means technique and the 
Bonferroni correction method on hormonal data after it was grouped into the three, 7-day time 
bins. Linear regression analyses were done to test for associations between cortisol and E1C and 
cortisol and PdG. 
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Chapter 5 
Results 
 During the course of this study both groups of female athletes, soccer and cross-country, 
showed changes in hormone and body composition levels. These changes occurred between the 
in-season (IS) levels and off-season (OS) levels.  These changes may reflect the differences in 
mental and physical stressors of competition and training as well as differences in nutritional 
intake versus expenditure during the IS and OS periods.  However, there were no reports of 
deficiencies leading to cessation of reproductive processes.     
 Energy balance (Fig. 4) differed (P<0.05) during IS training (-533 C,  967) compared to 
OS recovery (-48 C,  711) with athletes returning to a more balanced energetic state.  There was 
no difference in caloric intake between IS and OS (Fig. 5), however, expenditure differed 
significantly (P<0.01).  It is also interesting to note that soccer players showed a negative energy 
balance both IS and OS while cross-country runners maintained a positive energy balance for 
both.  There was no difference in body fat and weight between IS and OS for all participants 
(Figs. 3 & 4), but percent body fat decreased (P<0.05) from 23% ( 4.3) to 21% ( 3.7) for 
soccer players (not shown).  Although there were no significant differences, a trend toward 
weight loss and decreased body fat was seen. 
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Average macronutrient intake was below the recommended daily allowance (RDA) in all 
participants, for several important vitamins and minerals.  Sixteen of the seventeen participants 
were deficient for Vitamin D (not shown) with an average of 1.89 g/day (1.71) compared to 
RDA of 5.00 g/day.  Ten were deficient for calcium (646 mg/day,  307) vs. RDA of 1000 
mg/day; all were deficient for potassium (1815 mg/day,  790) vs. RDA of 4700 mg/day, at 
nearly half of the recommended daily level; thirteen were deficient in magnesium (194 mg/day, 
 57) vs. RDA of 310 mg/day (Fig. 6).  Nine were deficient in iron (10.6 mg/day,  3.6) vs. RDA 
of 18 mg/day.   
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Results from Hormonal Assays 
Hormonal profiles for E1C, PdG and cortisol are shown in Figure 7.  Hormonal value 
tables are provided in appendices.  Two-way ANOVA revealed day and season effects (P<0.005) 
toward increased levels of hormone production during the OS in EIC, PdG and cortisol values in 
contracepting and non-contracepting athletes.  Post-hoc comparisons revealed no significant 
differences between IS and OS values when comparing corresponding time bins for all 
hormones.  One-way ANOVA revealed that contraceptive use had a significant effect in both 
lowering and standardizing EIC and PdG levels, but not for cortisol.  Post-hoc comparisons for 
E1C revealed significant differences for all time bins except for the follicular bin (menstrual day 
2-9) during the OS (see Fig. 7A) with peak values around day 16 of the menstrual cycle.  E1C 
levels are also shifted several days forward with regard to initiation of ovulation and have three 
spikes and decreases during that phase rather than the distinct spike around days 13-15to initiate 
ovulation as was seen during the off-season.  For PdG, only comparisons during the luteal phase 
(menstrual days 21-28) in the OS revealed significant differences and showed increased PdG 
production during the OS (Fig. 7B).  It is interesting to note that we see an almost continually 
higher level of all hormones monitored for non-contracepting individual versus that of 
contracepting individuals, which was contrary to what we expected to find.   One-way ANOVA 
revealed significant (P<0.01) “sport effects” on E1C and PDG for contracepting and non-
contracepting athletes (Fig. 8).  Soccer players showed much higher levels at peak hormone 
production than did cross-country individual, however the reason for this is unknown.  There was 
no such effect for cortisol (not shown) which seemed to vary independently of our monitored 
variables.  Post-hoc comparisons for non-contracepting participants were significant in the 
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ovulatory and luteal time bins in the OS for E1C, but no differences were found for PDG in the 
IS or OS; in contracepting athletes there were no differences in any time bins in either season.  
Delta-values for E1C, calculated by taking the difference between IS and OS values on the same 
menstrual day, differed based on menstrual day and showed an increased level of hormone 
production OS.  This was not the case for PDG and cortisol.   
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Figure 8: Average E1C and PDG values for contracepting and non-contracepting female soccer 
(n=5, 3) and cross country (n=3, 5) athletes over two complete menstrual cycles.  Days 1-28 
represents values for in-season menstrual cycle and days 29-55 represent post season menstrual 
cycle E1C and PDG values.    
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Linear regression analysis revealed no significant association between cortisol and E1C 
for all participants (Fig. 9A).  However, there was a negative correlation (P<0.05) for 
contracepting participants in which cortisol explained approximately 7% of the variation in E1C. 
For soccer players there was a significant association (P<0.01) between cortisol and E1C 
explaining 4% of the variation in E1C (Fig. 9B).  The only significant correlation between 
cortisol and E1C for cross-country runners was in the contracepting participants (Fig. 9C). There 
was no significant association between cortisol and PDG for all participants (Fig. 9D).  A 
significant correlation (P<0.01) was found between cortisol and PDG for soccer players with 
cortisol explaining about 5% of the variation in PDG for contracepting players and about 19% in 
the non-contracepting players (Fig. 9E). There was no correlation for cortisol and PDG in cross-
country runners as a whole (Fig. 9F), however there was a significant (P<0.01) positive 
correlation in the contracepting runners explaining over 15% of the variation in PDG.   All 
statistical analysis tables can be found in Appendix J. 
Bone Densities 
All participants had bone densities that were average or above average when compared to 
a national data base with average Z-score for bone density at 1.88  1.4; range (-0.03 to 3.7).  
Individual stiffness indices had a large range from a low of 96 to a high of 194 indicating that 
there were varying levels of bone health between individuals.  The average bone density stiffness 
index for soccer players was 140.22 and 124 for runners.  There were no correlations between 
physical features such as height, weight and percent body fat with bone density or any nutrients 
linked to bone health.   
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Figure 9: Effects of cortisol on E1C and PDG levels for all athletes (n=17), soccer players (n=8) 
and cross country participants (n=9) during thirty five consecutive days of competition and thirty 
five consecutive days of non-competition.  Data is further broken down into contracepting vs. 
non-contracepting individuals. 
 
All Sports E1C Soccer E1C Cross‐country E1C All Sports PDG Soccer PDG Cross‐country PDG
Combined Subjects
y = ‐0.0371x + 56.454      
          R² = 0.0054
y = ‐0.1878x + 78.026
R² = 0.0355
y = ‐0.0166x + 50.284
R² = 0.0026
y = ‐0.0014x + 2.6455
R² = 0.0014
y = ‐0.0463x + 8.3651
R² = 0.0699
y = 0.0004x + 2.1952
R² = 0.0003
Non‐contracepting
y = ‐0.0189x + 68.289      
      R² = 0.0013 
y = ‐0.2265x + 99.596
R² = 0.0541
y = ‐0.0284x + 60.824
R² = 0.0092
y = ‐0.0057x + 3.7139
R² = 0.0124
y = ‐0.1047x + 18.034
R² = 0.1903
y = ‐0.0031x + 3.0572
R² = 0.0106
Contracepting
y = ‐0.0944x + 48.439      
        R² = 0.066 
y = ‐0.1814x + 69.51
R² = 0.0355
y = ‐0.0966x + 45.605
R² = 0.1224
y = 0.0004x + 1.9777
R² = 0.0004
y = ‐0.0108x + 3.3929
R² = 0.0448
y = 0.0046x + 1.0998
R² = 0.1669
R2 Values for Linear regression of cortisol versus E1C and PDG
Table 2:  Slope and R2 calculations for regression analysis of Cortisols effects on levels of E1C and PDG  
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Chapter 6 
Discussion 
 
Although the existence of the female athlete triad has been questioned by some 
researchers, (Dipietro and Stachenfeld, 2006) for example, most agree that the specific 
conditions that make up the components of the triad are very real and can be detrimental to the 
health of female athletes.  It is important to look at both the prevalence and severity of each of 
the three components of the triad (disordered eating/ negative energy, osteopoenia, and 
amenorrhea) in female athletes because of the potential detrimental effects.  It was hypothesized 
that the female athletes would show raised cortisol levels with  peak levels during competitive 
events due to stress, accompanied by lowered levels of reproductive hormones during the 
competitive season.  This was not the case with Western Washington University’s soccer and 
cross-country female athletes, who were healthy and showed only minimal signs of the triad.  
Hormone levels remained relatively robust during competition though levels did trend lower 
compared to the noncompetitive state.  Three athletes reported amenorrheic conditions prior to 
sample collections but returned to menstruation soon after.  This refuted our original hypothesis 
of declined menstrual functioning. There was a relative consistency of hormone levels, with no 
great decline during training. However, it is likely that some interesting hormonal interactions 
were missed during the initiation of the training season.   
There was a wide range in bone densities, but all fell within healthy ranges, though a few 
were on the low end of the healthy density spectrum.  The greatest concern comes in the area of 
energy balance and poor dietary choices as nearly all athletes were in a negative caloric balance.  
As hypothesized, athletes that were not compensating their caloric expenditure with intake fell 
below the recommended daily allowance for macronutrient and micronutrient levels. 
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Female collegiate athletes in this study exhibited negative caloric balances during their 
competitive seasons, and showed no difference in caloric intake in season verses post-season.    
Although energy remained in a negative state in season, reproductive hormone levels remained 
robust, with a slight increase in levels once athletes stopped training.   Survey data collected 
before the study started provided evidence of amenorrhea like conditions at the initiation of 
training for several of the participants.  This suggests that these women may be experiencing 
short periods of reproductive suppression brought about by adaptive mechanisms as described by 
Ellison (2003).  Ellison states that human females have developed physiological reproductive 
mechanisms to optimize reproductive effort.  These mechanisms work to suppress reproductive 
function during times of low energy availability and possibly even react to sudden changes 
towards negative energy balance, rather than just prolonged states.  In this case, we are most 
likely looking at the sudden change in output that is affecting the reproductive functions. 
 
Dietary Intake and Activity Reports 
In the current study, no participants were determined to be at risk for osteopenia as 
evidenced by bone density measurements and all fell in the above average bone mass group.  
Cross-country runners had an average bone stiffness index sixteen points lower than that of 
soccer players, which is quite a difference considering the above average scoring ranges between 
116-140 points.  Soccer involves a greater range of physical strains on the lower limbs including 
running, jumping, kicking, cutting and turning for example, as compared to cross country 
running.  Thus the greater demands placed on the skeleton may result in greater mineral 
deposition.     
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The results of the dietary and activity journals show that there is greater energy 
expenditure during an athletic season as compared to the off season.  This was expected due to 
the physicality that training, practice and competition require.  However, there was no difference 
found in the amount of calories consumed during IS vs. OS.  This suggests that athletes may 
limit their intake in spite of the demands, or that they simply cannot take in the calories needed 
based on their dietary selections. Methodological shortcomings may have also come into play.  
Dietary recall methods have been shown to result in underreporting of caloric intake (Klesges et 
al., 1995). The low caloric intake as compared to caloric expenditure resulted in lowered body fat 
after completion of the competitive season.  Also of note was the insufficient macronutrient 
consumption by the athletes.  All participants failed to meet RDAs for multiple macronutrients 
with some not consuming half of their RDAs. The results indicate that during periods of extreme 
energy expenditure, female college athletes do not adequately meet their caloric and nutritional 
needs.  If continued, this would produce poor health outcomes.  Increasing the number of 
dietary/activity journals administered would likely aid in a more normalized profile.  Any 
secondary runs should look at administering two-three day (72hr) entries both during and post 
season, with a minimum of three weeks separation time.  
When working with human participants, compliance is an issue, since it is up to the 
subjects to perform the tasks assigned to them.  In the case of dietary data collection, a detailed 
journal can provide great insight into the metabolic processes of an individual.  However, a 
journal that is lacking information such as portion sizes or when large periods of the day are 
unaccounted for is nearly useless.  Another confounding factor that may arise is the under-
reporting of caloric intake.  Klesges et al. (1995) showed that of a sample of 11,663 individuals, 
nearly 31% underreported their caloric intake.  They also found that female participants were 
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more likely to underreport than male counterparts.  There are many factors that might lead to 
underreporting of ingested calories.  These might include deliberate exclusion of items to try and 
portray a balanced input vs. output of calories and/or the exclusion of certain items for personal 
reasons, such as the number of alcoholic drinks ingested in one period.  Underreporting can also 
come from simply not recording the proper portion of calories ingested during a meal.  By 
having participants write down basic types and portions of food and then running this 
information through dietary analysis software, much of the underreporting, due to inexperience 
of recording food amounts, can be avoided.  The computer software has a database of thousands 
of everyday foods from basic fruit is, vegetables and grains to complete nutrition facts on store 
bought and fast food meals.  The data base provides a much quicker and easier way to enter the 
entire suite of nutrition components of a food item such as it is caloric, fat, vitamin and mineral 
components.  The program also helps to cut down on human error from incorrectly entering 
values for a specific item.  
The dietary analysis issues that arose during this study were mostly due to poor reporting 
of dietary intake.  Although the participants were given specific instructions on how to be as 
accurate as possible with portions and types of food, there were still instances of non 
compliance.  It is difficult to determine the exact caloric value of an item when no quantity or 
ingredients are given i.e. reporting a salad for dinner rather than specifics such as a cup of green 
lettuce, two baby carrots and a tablespoon of vinaigrette.  In these situations, the athletes were 
personally asked at the next meeting to try and recall in more detail the contents of that meal in 
an effort to increase accuracy.  Under or non-reporting is also suspected for alcohol consumption 
based on information gathered from daily activity journals and compared to those individuals 
who were complete with dietary recording.  An example of this was found when one of the 
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athletes reported having four beers with a group of girls included in this study, none of which 
reported drinking beer.  This may have been an issue of not wanting to report alcohol in an effort 
to stick to codes of conduct during season.  The non-reporting of alcohol can pose a problem in 
that there are many calories gained from the consumption of alcoholic beverages that would not 
show as intake in the journal.  This was only seen once and may account for some of the negative 
caloric intake vs. output days that were seen.  Although there were some reporting issues, the 
majority of dietary journals were correctly completed and provided useful and interesting results.  
 
Hormone Discussion 
 Low caloric availability brought about by exercise has been shown to result in 
hypoestrogenism (Laughlin & Yen, 1996; Loucks et al., 1998).   It was hypothesized that the 
training and competition during the sport season would create a situation of lowered estrogen and 
progesterone output.  Conversely, this study showed no dramatic effects of training on steroid 
hormone levels.  However, there were modest gains in E1C and PdG when moving from the 
competitive season to the off-season.  These differences appear to occur in the luteal phase, 
although the limitations of our analyses make it difficult to verify this.  Only one of seventeen 
participants reported amenorrhea during the study, although in the months immediately 
preceding the study three participants reported missed menses for a period of one to two cycles.  
I began monitoring participants after they had already participated in preliminary training and 
five weeks of competition.  Metabolic disruptions and subsequent reproductive suppression may 
have occurred during training but before the participants were contacted, since the initial effects 
of training may be more demanding on the un-acclimatized.  In the present study, prolonged 
exposure to high energy expenditure may have resulted in physiological and behavioral counter-
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regulatory mechanisms that prevented severe metabolic insults and allowed for proper 
reproductive function as evidenced by adequate steroid hormone output.   It is recommended that 
any future runs of this study start a minimum of two weeks prior to the initiation of training and 
not at the beginning of the competitive season. 
Results reveal that E1C, and to a lesser extent PdG, levels where elevated in soccer 
player compared to those of cross-country runners.  This supports the idea of a difference 
between lean and non-lean sport types with the relation of lowered levels of reproductive 
hormone output in athletes with lower levels of body fat.  While both soccer and cross-country 
are weight-bearing activities that are energetically demanding, they present different metabolic 
challenges for the participants.  Body weight is typically monitored and controlled in cross-
country (lean) but not so for soccer.  Muscle mass and upper body strength is generally 
considered beneficial in soccer, since soccer involves much more physical contact (non-lean).    
Furthermore, hormone levels increased more during the OS for soccer players compared to 
runners.  Personal interviews with athletes post season revealed that soccer players decreased 
their sport-related energy expenditures after the completion of the season to a greater extent 
compared to the runners.  After season completion, many soccer players continued to work out 
but no longer practiced or trained for matches whereas the runners continued to run at a fairly 
high intensity level, just not quite as often.     
Cortisol varied by menstrual day and by season, but no patterns emerged with respect to 
cortisol and menstrual day and/or effects of training.  There was no difference in cortisol 
between soccer players and runners as a whole.  In contrast to my hypotheses, cortisol values did 
not increase IS and decreases in the OS, nor was it negatively correlated with reproductive 
hormones on the whole.  However, cortisol was negatively correlated with reproductive 
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hormones in several subsets of the sample, although the amount of variation in E1C and PDG 
explained by the variation in cortisol was modest (ranging from about 4% to 20%).  Stronger 
correlations were found in soccer players compared to runners, which could be a result of an 
increased psychosocial stress involved with competitive soccer and team dynamics.  Cortisol 
varied on a daily basis and seemed to be unaffected by the metabolic fluctuations brought on by 
caloric restrictions and/or training.  Cortisol values also appeared to be un-influenced by the 
scheduled athletic competitions.  It is likely that the individual variations in cortisol levels were 
due to daily psychosocial stressors that were not reported in daily sample journals.  Woods et. al., 
(2009) found that psychosocial stressors and cortisol increases during a daytime period did not 
affect overall overnight cortisol levels.  This may be one reason we are not seeing the increase in 
cortisol during specified events due to the collection of urinary cortisol on the morning after.  
Examinations, interpersonal relationships, work and many other daily stressors all must influence 
cortisol output.  These factors surely confound the results and make interpretations difficult.  
Funding and collection availability permitting, salivary cortisol swabs would be recommended to 
be used at times of raised stress i.e. initiation of competition, tests, after an adverse social 
interaction etc. in an effort to capture levels in the moment rather than the following morning. 
Similar to the dietary analysis, there were a few methodological problems that arose in 
hormone sampling that lead to decreased sample numbers for the study.  Non-compliance was 
the major factor limiting subject samples as there were several days of missed sampling for the 
majority of participants, with one subject missing samples for the entire secondary sampling 
period.  This lead to smaller comparison groups as well as gaps in daily individual hormone 
profiles.  A larger sample size would have been much more ideal, and earlier set-up with coaches 
47 
 
and teams, as well as continuation of the study throughout an athlete’s carrier at WWU would 
greatly help to increase sample size and strengthen the study. 
Contamination of samples also posed a problem with reproductive hormone 
concentrations.  Some of our samples contained menstrual blood which greatly increased the 
hormone concentrations in the urinary samples.  These samples fell outside of the outlier ranges 
for our hormone values and due to extremely high concentrations as well as contamination; these 
samples were eliminated from all analysis.  The use of contraception by some athletes also 
distorted the natural levels of reproductive hormone variation in our sample population. 
 
Contraception Use 
Reproductive hormonal secretions are an essential part of ovarian function and also play 
a major role in the functioning of other reproductive organs such as the uterus, vagina, mammary 
glands and fallopian tubes (Griffin & Ojeda, 1996).  Although these hormones are primarily 
involved in reproductive function, they also play several key roles in maintaining homeostasis 
and healthy functioning of the body.  Estrogens have been implicated for hepatic production of 
binding proteins, increasing coagulation factors, increasing levels of high density lipoproteins 
while lowering low density lipoproteins, reducing bone resorption and as a major player in 
female reproductive cancers, heart disease and stroke (Brinton, 1996; FDA 2007; Gruber et al., 
2002; Holes, 2002; Silverthorn, 2009).  Progesterone is a neurosteroid that has been shown to 
affect synaptic function and may be relevant to memory function and regulation of apoptotic 
genes.  It has also been shown to aid in cell proliferation, osteoblast activity and as an anti-
inflammatory agent (Griffin & Ojeda, 1996).  Studies identifying possible receptors for 
secondary functions of LH and FSH not related to reproduction are lacking.  However, it is 
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shown that significant disruption of the concentrations of these two hormones may have an 
impact on reproductive cell proliferation and initiation of some cancers (Li  & Ganta, 2007; 
Parrott, et al., 2001; Zheng et al., 2000). 
An imbalance in the concentrations of reproductive hormones could lead to serious health 
problems and is therefore important to consider when reviewing the overall health of both 
reproductive and homeostatic function (Barton et al., 2002).  These hormones can be influenced 
through endogenous secretions or by exogenous/synthetic introduction as is the case with 
estrogen based contraceptive methods.  Aranda and Gallegos (1990) have shown that oral 
administration of estrogen can lead to a build-up of the hormone in both reproductive and 
peripheral tissues of the body and may be the cause of various negative side effects reported by 
women using birth control.  A similar study by White et al. (2006) showed that the form of 
contraception know as the “Patch” has considerable influence on hepatic protein production and 
may have a large affect on overall estrogen concentrations and influences in the body.  Oral 
contraceptives are shown to greatly increase the release of growth hormone during exercise, 
which can affect the overall health of the individual (Bernardes; Radomski, 1998).  Furthermore, 
exogenous administration is shown to negatively affect hepatic function as well as increase the 
risks of vascular inflammation known as atherosclerosis (Barton & Traupe 2002).   
The introduction of exogenous hormones can pose many problems when trying to deal 
with reproductive health as well as monitoring of reproductive hormones.  The use of hormonal 
contraceptives introduces unnaturally high levels of reproductive hormones to the body.  These 
contraceptive methods utilize synthetic estrogen, progesterone or a combination of both to create 
a situation in which sufficiently high levels of these hormones induce the negative feedback 
mechanisms on the release of GnRH from the hypothalamus as well as signaling the anterior 
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pituitary to cease production and release of LH and FSH (Griffin; Ojeda, 1996: Mishell R Jr; 
Kletzky et al., 1978).  Heightened levels of estrogen and progesterone can increase the risks of 
negative interactions in the body as described above, such as thrombosis, stroke and other 
clotting issues, as well as disrupt reproductive function as seen with amenorrhea.  The negative 
feedback mechanisms activated by these hormones may cause hypogonadism due to lack of LH 
and FSH stimulation as well as hypopituitarism (Griffin; Ojeda, 1996).  In the case of 
hypopituitarism, reproductive hormones can be diminished along with several other important 
steroid hormones, such as growth hormone and thyroid stimulating hormone which can lead to 
hyperthyroidism if not treated (MedlinePlus, 2007).  The possible risk for expression of these 
syndromes, due to interactions of exogenous hormone use, may be greatly multiplied when 
combined with the HPA suppressive effects of energetic stress that are often seen in athletes.  
 Exogenous hormones create a confounding variable when trying to monitor the natural 
changes of estrogen and progesterone concentrations over time.  There is yet to be a urinary 
assay developed that can distinguish between endogenous and exogenous forms of these 
reproductive hormones (Brindell, personal communication).   
Oral contraception was used by eight of the seventeen participants in the current study.  
Reproductive hormones were lower in contracepting athletes; presumably this was caused by the 
suppression of endogenous hormone production.  Since prolonged reproductive suppression can 
have negative effects on bone mineralization, the additive effects of contraceptive use and low 
energy availability may be troublesome for some athletes.  Even though contraceptive use makes 
interpretation of hormonal data difficult, it is important to include these participants in the study 
since the reality is that many college athletes use contraception and little is known on how 
excessive training influences the reproductive system in these women.  In this study, it appeared 
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that contraceptive use may have provided for a more stable and balanced level of reproductive 
hormones.  Beals & Manore, (2002) showed similar results in their assessment of triad 
prevalence with 31% of non contracepting athletes reporting some form of menstrual 
irregularities.  It may be possible that the athletes using contraceptives in this study were 
benefiting from this leveling effect, in that they did not experience large increases or declines in 
hormone levels, because of subjected artificial hormone intake. 
 
Hypotheses Revisited 
The results provide some support for the overall model that female college athletes will be in a 
state of lowered energy availability during the competitive season due to training and 
participation in their sport.  During this time we should see increased levels of cortisol and 
decreased levels of estrogen and progesterone as it should portray a somewhat chronic level of 
increased stress.  Furthermore, peaked levels of cortisol should be seen during acute stressful 
events such as competitions.  This will not be the case during the off-season, where decreased 
physical output and psychosocial stress should lower levels of daily cortisol concentrations and 
allow for increased levels of estrogen and progesterone production.   
 
 Overall body weight and percent body fat will decrease from the start of the season until 
completion of season.  Athletes who do not compensate expenditure with increased 
caloric and proper nutrient intake are expected to suffer from inadequate levels of 
important nutrients such as calcium and potassium.  
 
There was no significant difference between weight and percent body fat, although soccer 
players averaged a 2% decrease in BMI.  There was a significant difference between energy 
expenditure during the season versus that of post season, however there was no difference in the 
amount of calories consumed.  This led to negative energy balance during the season and 
deficiencies in many macronutrients including Vitamin D, Potassium, Magnesium, Iron and 
Calcium. 
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 Reproductive hormonal output will be lower during the competitive season due to low 
energy availability and/or increased energy output and increased levels of stress.  
Hormonal levels will recover after completion of the season as training tapers off and 
competition ceases. 
Levels of estrogen and progesterone remained robust although there were slight increases in both 
when moving from the competitive season and into the off-season.   
 
 Levels of systemic cortisol will increase with stress during the competitive season and 
decrease after completion of the season.  
Cortisol was not significantly correlated with any specific stressful event or when comparing 
season and non-season or soccer and cross-country.  Cortisol variation was most likely due to 
individual variations and daily psychosocial events that were not able to be monitored with this 
design. 
 
 Cortisol levels will be negatively correlated to reproductive hormones. 
When looking at the participants as a whole, cortisol levels did not reflect changes with relation 
to reproductive hormones.  However, there were correlations of cortisol levels and estrogen and 
progesterone when looking at subsets of the participants.  (negative correlations explaining 7% 
variation of E1C in contracepting participants; soccer players had variation of 4% E1C, 5% for 
contracepting and 19% non-contracepting PDG negative correlations; significant positive 
correlation explaining 15% of variation for cortisol and PDG in contracepting cross-country 
runners) 
 
 Overall reproductive hormone profiles during training will resemble those found in 
women of traditional populations with high energy output. 
This was not supported by the present research with participants following more closely to the 
theory of high initial output being the stressor on the reproductive system, with a quick return to 
normal function. 
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Conclusions  
Female collegiate athletes in this study exhibited negative caloric balances during their 
competitive seasons, and showed no difference in caloric intake in season versus post-season.  
Although energy remained in a negative state in season, reproductive hormone levels remained 
robust, with a slight increase in levels once athletes stopped training.  Cortisol seemed to be 
unaffected by the metabolic fluctuations brought on by caloric restrictions and/or training, nor 
did cortisol values appear to be influenced by the scheduled athletic competitions.  It is likely 
that the individual variations in cortisol levels were due to daily psychosocial stressors that were 
not reported in daily sample journals.  Cortisol was negatively correlated with E1C and PdG 
levels for soccer participants, though it was a fairly weak association.  There was no correlation 
found for cross country runners. Furthermore, soccer and cross country athletes showed little 
variation in hormone concentrations with significant differences only occurring in the ovulatory 
and luteal phases of non contracepting individuals.  This population did not exhibit the female 
athlete triad, though many individuals were low in both caloric and nutritional intake and showed 
signs of moderate risk of developing at least one of the major components of the syndrome. 
Female athletes provide a means by which to study high energy output in a natural 
setting.  Furthermore, female athletes make up a fairly large and important part of the 
demographic for women at reproductive age.  Thus issues regarding immediate and long term 
health for athletes are important in their own right.  The current study suggests that US women 
are resilient with respect to heavy-duty training and competition, and maintain robust ovarian 
cycles in the face of training.  This may be due to the accessibility of calorically dense foods 
which offset the high energy expenditures.  Although the sample showed negative energy 
balances in association with energy intake, we cannot dismiss the possibility of misreporting or 
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underreporting in dietary/activity journals.  This suggests that there are other mechanisms 
contributing to the cessation of menses in American female athletes that are not under caloric 
duress.  More research is needed regarding the specific mechanisms effecting American female 
collegiate athletes and how each component of the triad is affecting both short and long-term 
health. 
A secondary run of this experiment is needed to provide a larger sample size for strength 
of statistical analysis and comparisons.  A much greater emphasis needs to be placed on 
compliance with athletes being held responsible for quality record keeping.  A few athletes  
reported some amenorrheic conditions before the season began, then returning to normal 
menstrual function.  Starting the observations during training for the season and continuing for a 
greater period post season would provide a more complete picture of the body composition and 
hormonal changes that are occurring.  I believe that with these changes, the current methodology 
can provide useful data in which to analyze the effects of collegiate sports on female athletes. 
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Appendix A 
 
Physiology of Stress 
 
The stress response is regulated by the central and peripheral nervous systems (CNS, 
PNS) (Charmandari, 2005).  The CNS is comprised of the brain and spinal cord while the PNS is 
composed of the cranial and spinal nerve systems that connect the brain to the somatic and 
autonomic nervous systems (SNS, ANS) (Holes, 2002).   The somatic motor nervous system 
controls voluntary movement of musculature and the autonomic division controls independent, 
unconscious functions such as heart rate and digestion (Silverthorn, 2004).  Furthermore, the 
ANS innervates various organs of the body providing a mechanism for the CNS to respond to 
changes in homeostatic conditions and bring about changes throughout the body including 
innervations to the respiratory, cardiac, renal, endocrine, respiratory and other organ systems in 
order to restore homeostasis (Silverthorn, 2004).  The ANS is comprised of two divisions, the 
sympathetic and parasympathetic branches.  The sympathetic branch is generally responsible for 
preparing the body for energy-expenditure and dealing with stressful situations as in the “fight or 
flight response.”  The parasympathetic division is responsible for restoring the body to restful 
conditions after a behavioral response controlled by the sympathetic system and usually exerts 
the most regulation during resting conditions (Holes, 2002).  
Visual input is processed in the inferior temporal gyrus, while auditory input is handled at 
the superior temporal gyrus.  Somesthetic input or the brain’s perceived image of somatosensory 
input, such as pressure or temperature changes are handled within the insular cortex (Cacioppo, 
2000).  The frontal cortex synthesizes the various sensory signals into a coherent understanding 
of what is occurring to the body.  The picture formed at the frontal cortex is also emotionally 
evaluated at the amygdale.  If there is a large enough emotional change required, appropriate 
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stress responses will release effecter hormones through the hippocampus, autonomic and 
endocrine response systems.  This hormone release may be further evaluated and provide 
feedback to the frontal cortex to either continue or stop the release of these hormones (Cacioppo, 
200).  The complex interactions of the limbic system and sensory input regions of the brain allow 
psychosocial stressors to be processed and relayed accordingly to activate the stress response 
system.  The limbic system of the brain is responsible for emotions and includes the 
hippocampus and portions of the prefrontal cortex (Holes, 2002).  The amygdala is a group of 
neurons found in the medial temporal lobes of the brain and connect through synapses with the 
hypothalamus.  They are involved in sympathetic response mechanisms in the brain and are also 
involved in the emotions of fear, jealousy and aggression (Kandel, 2000). 
The hippocampus is involved in memory and may be vital for long term storage of 
information (Holes, 2002). The prefrontal cortex is believed to be responsible for complex 
behaviors such as monitoring appropriate social behaviors and personality and outward 
expressions of these behaviors.  The limbic system integrates the sensory regions of the brain in 
order for the body to respond quickly and appropriately to psychosocial However, different 
regions of the brain have been identified to respond to varying stimuli.   
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Appendix B 
Ovulatory Detection Methods 
The ability to determine the presence or absence of ovulation relies on the detection of 
reproductive hormonal markers.  There have been various methods developed that rely on 
urinary hormones (LH, FSH, hCG and estrogen) for ovulatory detection (Baird et al., 1995; 
Kassam et al., 1996; Li et al., 2002).  It is important that these methods be both accurate and 
precise for determining ovulation, allowing for the earliest detection possible.  O’Conner et al. 
(2005) compares the performance of several of the existing detection methods as well as 
proposing new approaches to increase accuracy and precision of methods for the detection of 
ovulation.  Studies have also been done to evaluate the effects of irregular hormonal levels due to 
training and competition and how they affect current methods for determining ovulatory status 
(McConnell and O’Conner, 2002).  This may be further confounded by the use of contraceptives 
and the interactions of endogenous and exogenous hormones of the hypothalamic pituitary 
ovarian axis (HPO). 
 This 69nergetic project utilized two data sets that could help determine ovulatory status.  
The first is a questionnaire based form in which individuals where asked to describe significant 
changes in stress (physiological or psychological), any significant dietary change, and any 
medication changes.  Information on day of contraception (if applicable) and whether or not they 
were experiencing menses and/or any form of amenorrhea was also collected.  This information 
was recorded each morning upon collection of that day’s urine sample and extended over a 72 
day period.    
 The second data set consists of daily collections of the first morning’s urinary expulsion.  
Baird et al., (1991) suggested a method to estimate day of ovulation by monitoring the shift from 
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follicular estrogen production to that of luteal progesterone.  PdG has been used with an 
algorithmic ratio of PdG to Creatine (CR), by which daily PdG/CR values where divided by a 
calculated baseline PdG level (Kassam et al., 1996).  This model states that ovulation has 
occurred if PdG ratios are greater than or equal to three, for three or more consecutive days.   
More precise and accurate algorithms and methods for estimation of presence or absence of 
ovulation through urinalysis have been proposed by O’Connor et al. (2006).  In O’Connor’s 
study, methods for ovulatory detection using E1C and PdG where monitored as well as methods 
of ovulatory detection by means of LH and FSH concentrations.  The tests that yielded the most 
accurate and sensitive detection for ovulation were then combined with algorithmic estimates for 
day of ovulation.  
 From this work, O’Connor et al. (2006) believe that the PdG algorithm proposed by 
Kassam et al., (1996) is the most effective at identifying a cycle as being ovulatory.  However, 
LH and FSH provided much more precision and accuracy when looking for markers to determine 
day of ovulation (Aedo, et al., 1976; Li et al. 2002; O’Connor et al. 2006; Santoro et al., 2003).  
After evaluating the data presented by O’Connor et al., (2006), the Kassam model for predicting 
ovulatory status appears to fit well with the current data.  It allows for the most accurate and 
precise method for detecting ovulation using PdG, one of the four biomolecules of interest to our 
study.  By using the Kassam model with a sampling design of every other day, it would be 
possible to monitor PdG levels on an intermittent scale which would also be conducive to 
situations in which a daily urinary sample was missed.  By adapting these methods to our study, 
it would be possible to look at reproductive health by means of cycle quality as expressed by 
ovulation as well as monitoring changes in hormonal profiles as the athletic season progresses. 
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Adapted from Silverthorn 2004 
 
 
Figure 10: Hypothalamic – ovarian flow chart for the hormones involved in reproduction. 
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Appendix C 
Glossary of Terms 
 
Reproduction 
Amenorrhea:  An absence of menses in a woman of reproductive age. 
 
Corpus Luteum:  A temporary endocrine gland responsible for the production of progesterone. 
 
Estrogens:  A group of steroid hormones produced primarily in ovarian follicles and are involved 
in regulating the menstrual cycle and in the development of secondary sexual characteristics. 
 
Follicle: A small ovarian sac containing an immature ovum. 
 
Follicular Phase:  First stage of the menstrual cycle in which follicles in the ovary mature for 
ovulation. 
 
Follicular Stimulating Hormone:  A hormone released by the anterior pituitary gland that 
stimulates the release of a follicle. 
 
Gonadatropin Releasing Hormone: A hormone released from the hypothalamus that stimulates 
the release of luteinizing and follicular stimulating hormones. 
 
Inhibin:  A peptide that inhibit is the synthesis and release of follicular stimulating hormone. 
 
Luteal Phase:  The second stage in the menstrual cycle that begins with ovulation and the 
formation of a corpus luteum and ends with pregnancy or menstruation. 
 
Luteinizing Hormone:  A hormone produced by the anterior pituitary gland that when at peak 
levels stimulates ovulation. 
 
Oligomenorrhea:  Abnormally infrequent or light menstrual flows. 
 
Ovarian Cycle:   A recurring sex cycle in females that includes development of an ovarian 
follicle, rupture of the follicle, discharge of the ovum, and formation and regression of a corpus 
luteum.  It is composed of the follicular, ovulatory and luteal phases. 
 
Ovum: A haploid female reproductive cell. 
 
Progesterone:  A hormone produced in the ovaries and is involved in readying the uterus for 
implantation of an egg and in development of the fetus. 
 
Reproductive function:  The complex system of physical and hormonal interaction involved in 
the female reproductive cycle. 
 
73 
 
Female Athlete Triad:  A syndrome seen in female athletes consisting of the interplay of three 
different disorders:  low energy availability (with or without disordered eating), amenorrhea and 
osteoporosis. 
 
 
Stress 
Adrenal Cortex:  Outer portion of the adrenal glands that secrete cortisol and aldosterone. 
 
Adrenocorticotropic Hormone (ACTH):  A polypeptide hormone produced in the anterior 
pituitary in response to stress that stimulates the adrenal cortex. 
 
Autonomic Nervous System:  A system of nerves and ganglia that control the involuntary 
functions of the sympathetic and parasympathetic nervous systems. 
 
Central Nervous System (CNS):  The portion of the nervous system comprised of the brain and 
spinal cord. 
 
Cortisol:  A steroid hormone produced by the adrenal glands. 
 
Corticotropin Releasing Hormone (CRH):  A hormone released from the hypothalamus that 
stimulates the anterior pituitary gland to release ACTH. 
 
Glucocorticoids: A group of steroid hormones such as cortisol produced in the adrenal glands 
that facilitate metabolism and have ani-inflammatory properties. 
 
Metabolic Stress:  Metabolic stress refers to the stress the body undergoes when energy 
expenditure is not matched by intake as well as any stress incurred due to metabolic processes. 
 
Parasympathetic Nervous System:  A branch of the autonomic nervous system that deals with 
processes involved with a relaxed state such as digestion. 
 
Peripheral Nervous System (PNS):  the PNS is composed of the cranial and spinal nerve systems 
that connect the brain to the somatic and autonomic nervous systems. 
 
Physical Stress:  Stress that threatens the tissues of the body such as injury, infection, fatigue and 
temperature extremes. 
 
Psychosocial stress:  Psychosocial stress can be activated by any negative emotional disturbance 
in which a person feels they are in danger, in a perceived stressful situation, faced with failure or 
are in an unfamiliar situation 
 
Stress: Stress refers to the body’s mental and physical reactions to any stimuli that threaten to 
disrupt homeostasis. 
 
Sympathetic Nervous System (SNS):  A branch of the autonomic nervous system that deals with 
stress and the fight or flight response. 
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Appendix H 
Average E1C Levels in Season  Average E1C Levels Post Season 
non‐contracepting  contracepting  non‐contracepting  contracepting 
56.51808221  43.46757286 49.25188452 28.363945
40.87256437  27.234006 56.20707203 45.80100625
51.68780245  26.909075 64.30838116 29.543708
43.73671534  26.68391 46.09986111 28.99431857
43.29602427  32.27441167 42.72188314 33.33442429
42.01313192  36.949402 51.51073602 37.08888875
46.13092462  34.902418 49.26848029 36.2129
51.88278448  38.51495667 57.33037649 34.25117143
59.62448059  26.451372 55.02510398 34.75354571
46.70314804  34.489974 45.99722505 40.31914
79.98182222  39.54987 66.81607864 31.16213
64.18561003  30.6826675 54.4800314 30.43596333
47.37075258  35.35273333 54.43135371 40.557042
51.71602998  32.93746167 88.29566227 33.16477
49.89415084  31.58809167 63.90072863 29.63948833
97.00631933  39.56829 104.94025 64.41597429
101.2543728  49.47789429 142.7356992 51.99228857
70.45479711  58.44225143 91.16292701 72.71300167
78.76784665  49.27016286 103.2637445 67.83437571
97.98477214  30.90978667 105.5831167 46.95879
89.94045581  27.239838 109.3996752 40.159304
61.9692614  31.48371 70.70036897 51.119726
74.09193341  46.85747333 103.0427533 44.93277167
96.21162155  32.10507833 90.75553787 34.568878
75.15433439  38.31515857 84.43454674 37.94671
77.9828317  40.49859286 75.47144027 34.85752
75.12259723  39.53143857 86.14933965 36.58869833
66.09105609  46.10814 72.66649178 49.631305
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Average PDG Levels/1000 In Season  Average PDG Levels/1000 Post 
Season 
non‐contracepting  contracepting       
1.67672372  2.129515565 2.109508643 1.855601795
1.807553449  1.817959227 1.441791334 1.94379858
1.832278512  1.296446608 2.525570078 2.132810088
1.767978491  2.054384333 1.578328873 1.931700762
2.01855636  2.460855294 2.496156514 1.719820804
2.092792134  1.759097387 1.875061295 1.717028442
2.205649162  2.211621237 1.804588724 1.860830316
2.019832214  2.062345378 2.139040548 2.163704366
1.627187638  1.991408893 1.427624054 2.29417859
1.616901403  1.650340647 1.599743868 2.329157436
1.610605091  1.909680282 1.903304833 2.543982373
2.19572526  2.59819134 1.931982366 1.922959915
1.433402856  2.3562185 1.877655866 1.974171315
1.839152561  2.415165564 2.521939508 2.05786946
1.76811264  1.861770368 2.411577641 1.987837539
2.538313057  2.003714483 3.984591393 1.409279488
2.806428593  2.478150108 1.600788012 1.477162132
2.412301905  1.76828287 4.349641891 1.544724923
2.564570752  2.107748293 3.919485703 1.616515038
3.529651702  2.063363269 4.36411603 1.804837123
2.271151501  1.397637929 6.514283091 1.822858006
5.215614315  2.258786939 6.980898151 2.64957675
3.449246434  4.661607839 6.287611812 3.28362314
3.19886197  1.997898433 4.24883173 1.691499444
3.618724988  2.001564728 6.866735808 1.905910716
7.769376859  2.279678699 10.34820424 2.276050948
3.510485401  1.643213843 4.95194525 1.931125704
3.119190732  2.044242198 1.889896492 1.779972995
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Average Cortisol Levels In Season  Average Cortisol Levels Post Season 
non‐contracepting  contracepting  non‐contracepting  contracepting 
105.0524904  86.4793362 145.0633629 98.26004211 
123.6081226  85.61600889 68.20068458 111.882819 
100.9357463  116.6214368 78.55003957 122.7465685 
120.1577943  57.36634706 129.1757497 75.17064458 
86.73532639  94.99554557 86.34322001 83.71237515 
143.2941676  57.80243856 92.67041764 49.50688521 
81.94431148  62.67870166 104.9626089 53.50852003 
92.50953222  122.9256731 109.3304419 98.40447295 
109.5610314  80.32276372 79.50719991 98.18765359 
105.7188543  100.6608761 85.40246449 133.6005676 
101.2436436  78.66978248 86.20504856 99.99494924 
95.98706585  93.26222505 113.9503865 81.58040253 
68.12965997  120.6236007 156.1479492 101.8295523 
73.87181445  119.3734826 110.9228573 71.34589618 
109.011782  73.74447155 198.7179214 127.791063 
85.49348311  74.97526562 124.6017993 100.525979 
81.85741  79.90654408 37.18849031 62.06055014 
89.98300685  91.73658475 187.0256546 83.14837566 
109.7376546  97.73701827 133.5654331 94.0858876 
110.5844252  83.0641809 166.9496702 64.36939032 
68.31043142  64.57258119 81.02508573 80.93980695 
98.95938966  98.39129326 64.20767648 151.5814435 
168.4794152  93.01320227 77.48310776 98.19395276 
109.1834771  86.20874062 97.13031431 77.91890705 
103.142675  115.3132617 86.80437993 105.9831821 
176.5034223  101.1231648 147.712817 162.9874878 
111.182122  112.9261453 153.1096831 106.6470137 
80.82160284  83.01455856 73.37434469 117.2603063 
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Average E1C Values for Non‐Contracepting 2 
Cycles 
Average E1C Values for Contracepting 2 Cycles 
soccer  cross‐country  soccer  cross‐country 
36.061945  66.2308425 47.59249 33.15528
39.410415  41.292658 29.4962125 18.18518
60.60001667  40.8233375 26.64629333 27.69742
51.34110667  45.998282 30.148595 19.75454
36.90676  46.067661 34.23747 28.348295
34.630795  36.3496022 41.16706333 30.62291
35.83716667  39.0696734 37.40675667 31.14591
39.357315  38.8660666 42.188104 20.14922
60.010745  44.8624178 29.693775 13.48176
47.842105  45.973444 37.70724 21.62091
93.76296  65.882374 45.43945 21.88113
83.19058  67.45213 34.94172667 17.90549
45.581745  47.809296 33.109415 39.83937
44.208065  55.76854 36.468335 25.875715
41.56070143  55.30309 36.4412525 21.88177
86.8059606  87.310362 44.4475325 29.809805
80.94570024  96.726594 61.604696 19.16089
73.75407321  74.903866 72.948242 22.177275
47.04412286  74.59649 59.679768 23.24615
66.54603917  87.908406 35.0754325 22.578495
69.79953548  81.769102 28.60274 25.195485
50.50892536  71.80144 33.55833 23.18523
36.16905714  86.197162 60.436435 19.69955
87.9026144  92.572774 35.55767 25.199895
39.94345607  84.869922 41.56999 30.17808
53.69036369  73.84815667 46.563346 25.33671
42.43707  78.332834 41.4183 34.814285
73.95829964  58.13092 54.2268375 29.870745
   49.02353 21.57663 41.938575
46.64972  56.59847333 46.373474 44.84689333
85.953885  44.31221667 26.9886025 39.76413
51.042475  39.34486667 26.841385 31.86489667
40.06789  41.71652667 32.8854375 33.93307333
56.07637  50.0761125 36.573528 37.94782333
41.42351  50.9957275 39.30220333 33.12359667
56.3808  54.619855 28.6965 41.6574
64.453585  47.32539 34.071925 35.66237333
47.47726  45.28564 32.73278 50.43428667
89.019915  44.29963333 33.19175667 29.13250333
53.50301  54.41113333 35.656325 19.99524
58.21414  52.131515 38.278375 42.07615333
74.32012  76.88562667 26.1699 37.82801667
68.40317  57.7989575 33.584515 21.749435
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Average PDG Values for Non‐Contracepting 2 
Cycles 
Average PDG Values for Non‐Contracepting 2 
Cycles 
soccer  cross‐country  soccer  cross‐country 
0.831923571  1.887923757 2.150155599 2.088235497
1.628289625  1.879258979 1.962771386 1.600740989
1.794393186  1.851221176 1.506025275 0.982078608
0.8104421  2.150993047 2.307683783 1.547785433
1.686244464  2.151481118 2.613530274 2.155505335
2.108691986  2.086432193 1.700094135 1.877103889
3.265777452  1.781597847 2.09176836 2.451326991
1.962216278  2.042878589 1.82112139 2.665405347
1.13716  1.725193166 2.192835672 0.984275
1.5813105  1.625799128 1.618290716 1.714440509
1.990708333  1.51557928 1.834701339 2.284575
1.70507  2.293856312 3.506054682 1.236396327
1.826415313  1.335149742 2.950198195 0.871269263
1.214339231  1.964115227 2.793133973 1.470244542
   1.76811264 2.116273803 1.225511782
3.518236333  2.146343746 2.074597906 1.861947636
4.355790556  2.186683808 2.836298231 1.761853862
3.994857045  1.779279849 1.859623363 1.585601885
3.123467569  2.341012025 1.869537561 2.465064391
2.986751741  3.746811686 1.925181976 2.270635208
1.880756032  2.466349235 1.151811018 1.88929175
2.76854945  6.439146748 2.050005673 2.676349471
3.014597813  3.666570745 5.83554937 2.313724776
140.132685  72.94612667 76.9986475 47.63907667
225.84102  106.1192 67.37315 31.48447333
93.86109  88.6104075 73.8695525 70.3999
118.34028  89.9648175 66.771225 69.25191
127.354735  88.8270075 51.29268333 42.62489667
123.815325  86.13309333 39.991335 40.27128333
93.80272  65.24259 67.31861 26.8214
117.26143  94.12518 51.05994 38.80560333
105.981865  70.1651325 40.98527 30.29128333
91.18244  69.77267 39.10520333 36.20897
75.47518  77.8205775 39.70492333 30.01011667
58.99935  96.9103925 42.9186875 23.92872
47.95491  78.113755 59.128084 33.80334
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3.752895804  2.921845054 2.064252786 1.898366905
3.003959483  3.926107741 2.373846832 1.443141571
11.81214661  5.343715009 2.521589299 1.7958575
4.226613333  3.224034228 1.384147257 2.161347016
3.241964633  3.070081172 2.011019164 2.09407675
   2.109508643 1.972923356 1.699173046
   1.441791334 1.68265244 2.291993432
2.036414167  2.688622049 2.346540254 1.705349756
1.87496  1.479451831 1.923158134 1.945938476
1.55992069  2.808235122 1.479951505 2.039646537
1.046681333  2.082156286 1.622763941 1.874135944
0.666586667  2.089089238 1.476912794 2.244747838
2.441245806  1.987937919 2.011259047 2.366964793
1.461456923  1.419165837 1.814065844 3.094366499
   1.599743868 2.303550456 2.371835737
1.780060952  1.934115803 2.61483026 2.449518524
1.379315263  2.070149141 2.915644229 0.599380829
1.515061739  1.998520575 2.004568669 1.928575283
   2.521939508 2.484545625 1.773418683
1.561077143  2.624202766 1.803486863 2.233638441
1.468905  4.613512991 1.483648989 1.334909988
1.820366667  1.527595127 1.46440359 1.489920674
4.046151579  4.425514469 1.575914946 1.513534901
2.518734615  4.269673475 1.480778467 1.707006085
2.170887059  4.912423273 1.230623806 2.37905044
8.178566364  5.959522 1.871283373 1.774432639
9.940745632  4.021050669 2.811245908 2.487907593
6.804962143  6.115161702 4.738025847 1.829220432
3.020205  4.658373973 1.637628403 1.745370486
9.397381797  5.601412813 2.20036643 1.513303099
15.10185182  7.179105848 2.249746375 2.302355521
3.901609473  5.652169102 2.051872801 1.770129576
0.953974554  2.513844451 1.952298759 1.550205309
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Appendix I 
Immunoassay Protocols 
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Appendix J (Statistical Tables) 
E1C Regression Analysis
Soccer E1C all subjects
SUMMARY OUTPUT
Regression Statistics
Multiple R 0.18838512
R Square 0.03548895
Adjusted R Sq 0.03352056
Standard Error 47.1288505
Observations 492
ANOVA
df SS MS F Significance F
Regression 1 40045.68797 40045.69 18.02943 2.603E‐05
Residual 490 1088352.99 2221.129
Total 491 1128398.678
Coefficients Standard Error t Stat P‐value Lower 95% Upper 95% Lower 95.0% Upper 95.0%
Intercept 78.0259281 3.970782755 19.65001 8E‐64 70.224066 85.8277897 70.2240664 85.8277897
X Variable 1 ‐0.18781095 0.044231319 ‐4.246108 2.6E‐05 ‐0.2747174 ‐0.1009045 ‐0.2747174 ‐0.10090451
Soccer E1C non‐contracepting
SUMMARY OUTPUT
Regression Statistics
Multiple R 0.23249192
R Square 0.05405249
Adjusted R Sq 0.04761748
Standard Error 51.6411034
Observations 149
ANOVA
df SS MS F Significance F
Regression 1 22400.46587 22400.47 8.399744 0.0043277
Residual 147 392020.1229 2666.804
Total 148 414420.5888
Coefficients Standard Error t Stat P‐value Lower 95% Upper 95% Lower 95.0% Upper 95.0%
Intercept 99.5955574 7.484030873 13.30774 5.13E‐27 84.805367 114.385748 84.8053666 114.385748
X Variable 1 ‐0.22651577 0.078156558 ‐2.898231 0.004328 ‐0.3809714 ‐0.0720602 ‐0.3809714 ‐0.07206018  
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Soccer E1C contracepting
SUMMARY OUTPUT
Regression Statistics
Multiple R 0.18851401
R Square 0.03553753
Adjusted R Sq 0.0327092
Standard Error 42.7227703
Observations 343
ANOVA
df SS MS F Significance F
Regression 1 22933.75349 22933.75 12.56482 0.0004479
Residual 341 622405.1703 1825.235
Total 342 645338.9238
Coefficients Standard Error t Stat P‐value Lower 95% Upper 95% Lower 95.0% Upper 95.0%
Intercept 69.5099459 4.455650076 15.60041 8.66E‐42 60.745927 78.2739648 60.745927 78.2739648
X Variable 1 ‐0.18144379 0.051187504 ‐3.544689 0.000448 ‐0.2821268 ‐0.0807608 ‐0.2821268 ‐0.08076079  
 
E1C Regression Analysis
Cross Country all Subjects
SUMMARY OUTPUT
Regression Statistics
Multiple R 0.05051413
R Square 0.002551677
Adjusted R Sq 0.000226623
Standard Error 22.00445911
Observations 431
ANOVA
df SS MS F Significance F
Regression 1 531.3908182 531.391 1.09747 0.295411858
Residual 429 207720.1786 484.196
Total 430 208251.5695
Coefficients Standard Error t Stat P‐value Lower 95% Upper 95% Lower 95.0% Upper 95.0%
Intercept 50.28413061 2.306737057 21.7988 1.9E‐71 45.75021806 54.818043 45.7502181 54.81804316
X Variable 1 ‐0.016582202 0.015828723 ‐1.0476 0.29541 ‐0.0476937 0.0145293 ‐0.0476937 0.014529296  
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Cross Country E1C non‐contracepting
SUMMARY OUTPUT
Regression Statistics
Multiple R 0.095823126
R Square 0.009182071
Adjusted R Sq 0.005371233
Standard Error 20.94292992
Observations 262
ANOVA
df SS MS F Significance F
Regression 1 1056.805433 1056.81 2.40946 0.121820137
Residual 260 114037.6415 438.606
Total 261 115094.4469
Coefficients Standard Error t Stat P‐value Lower 95% Upper 95% Lower 95.0% Upper 95.0%
Intercept 60.82415517 2.862709325 21.2471 9.1E‐59 55.18710851 66.461202 55.1871085 66.46120183
X Variable 1 ‐0.0284105 0.018302853 ‐1.5522 0.12182 ‐0.0644512 0.0076302 ‐0.0644512 0.007630196
Cross Country E1C contracepting
SUMMARY OUTPUT
Regression Statistics
Multiple R 0.349806777
R Square 0.122364782
Adjusted R Sq 0.117109481
Standard Error 14.91337646
Observations 169
ANOVA
df SS MS F Significance F
Regression 1 5178.581666 5178.58 23.2841 3.13339E‐06
Residual 167 37142.26916 222.409
Total 168 42320.85083
Coefficients Standard Error t Stat P‐value Lower 95% Upper 95% Lower 95.0% Upper 95.0%
Intercept 45.60519567 2.550123919 17.8835 1.2E‐40 40.57056018 50.639831 40.5705602 50.63983117
X Variable 1 ‐0.096570451 0.020013121 ‐4.8254 3.1E‐06 ‐0.13608177 ‐0.057059 ‐0.13608177 ‐0.057059128
 
 
 
 
 
115 
 
All non‐contracepting subjects E1C
SUMMARY OUTPUT
Regression Statistics
Multiple R 0.25134318
R Square 0.06317339
Adjusted R Sq 0.06088287
Standard Error 36.7034331
Observations 411
ANOVA
df SS MS F Significance F
Regression 1 37154.5224 37154.52 27.58026 2.429E‐07
Residual 409 550981.0778 1347.142
Total 410 588135.6002
Coefficients Standard Error t Stat P‐value Lower 95% Upper 95% Lower 95.0%Upper 95.0%
Intercept 81.5286616 3.488806287 23.36864 2.48E‐77 74.670433 88.3868907 74.6704325 88.3868907
X Variable 1 ‐0.13320746 0.02536468 ‐5.251691 2.43E‐07 ‐0.1830689 ‐0.0833461 ‐0.1830689 ‐0.08334605  
All contracepting subjects E1C
SUMMARY OUTPUT
Regression Statistics
Multiple R 0.267938377
R Square 0.071790974
Adjusted R Sq 0.069970956
Standard Error 36.68462586
Observations 512
ANOVA
df SS MS F Significance F
Regression 1 53083.85113 53083.9 39.4452 7.23157E‐10
Residual 510 686338.5052 1345.76
Total 511 739422.3563
Coefficients Standard Error t Stat P‐value Lower 95% Upper 95% Lower 95.0% Upper 95.0%
Intercept 65.80687933 3.137033379 20.9774 6.6E‐71 59.6437811 71.969978 59.6437811 71.96997756
X Variable 1 ‐0.192869769 0.030709097 ‐6.2805 7.2E‐10 ‐0.25320167 ‐0.132538 ‐0.25320167 ‐0.13253787  
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All subjects combined E1C
SUMMARY OUTPUT
Regression Statistics
Multiple R 0.03590079
R Square 0.00128887
Adjusted R Sq ‐0.00193278
Standard Error 35.2959603
Observations 312
ANOVA
df SS MS F Significance F
Regression 1 498.4019407 498.4019 0.400064 0.5275223
Residual 310 386199.4918 1245.805
Total 311 386697.8937
Coefficients Standard Error t Stat P‐value Lower 95% Upper 95% Lower 95.0% Upper 95.0%
Intercept 68.2892009 3.833411655 17.81421 2.24E‐49 60.746404 75.8319974 60.7464043 75.8319974
X Variable 1 ‐0.0189201 0.02991291 ‐0.632506 0.527522 ‐0.0777781 0.03993791 ‐0.0777781 0.03993791  
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PDG regression analysis
Soccer PDG all subjects
SUMMARY OUTPUT
Regression Statistics
Multiple R 0.26445086
R Square 0.06993426
Adjusted R Square 0.06796794
Standard Error 7.62804662
Observations 475
ANOVA
df SS MS F Significance F
Regression 1 2069.493803 2069.494 35.5662 4.83062E‐09
Residual 473 27522.49605 58.1871
Total 474 29591.98985
Coefficients Standard Error t Stat P‐value Lower 95% Upper 95% Lower 95.0%Upper 95.0%
Intercept 8.36513688 0.68479161 12.21559 5.11E‐30 7.019526907 9.71074686 7.01952691 9.71074686
X Variable 1 ‐0.0462999 0.007763567 ‐5.96374 4.83E‐09 ‐0.061555245 ‐0.0310446 ‐0.0615552 ‐0.0310446
Soccer PDG non‐contracepting 
SUMMARY OUTPUT
Regression Statistics
Multiple R 0.43623641
R Square 0.19030221
Adjusted R Square 0.18479406
Standard Error 11.1908939
Observations 149
ANOVA
df SS MS F Significance F
Regression 1 4326.809424 4326.809 34.54922 2.67872E‐08
Residual 147 18409.70778 125.2361
Total 148 22736.5172
Coefficients Standard Error t Stat P‐value Lower 95% Upper 95% Lower 95.0%Upper 95.0%
Intercept 18.0343238 1.670742335 10.7942 2.29E‐20 14.73254718 21.3361004 14.7325472 21.3361004
X Variable 1 ‐0.1047034 0.017813182 ‐5.87786 2.68E‐08 ‐0.139906361 ‐0.0695004 ‐0.1399064 ‐0.0695004  
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Soccer PDG contracepting
SUMMARY OUTPUT
Regression Statistics
Multiple R 0.21170881
R Square 0.04482062
Adjusted R Square 0.04187254
Standard Error 2.09851595
Observations 326
ANOVA
df SS MS F Significance F
Regression 1 66.95183506 66.95184 15.2033 0.000117365
Residual 324 1426.821222 4.403769
Total 325 1493.773057
Coefficients Standard Error t Stat P‐value Lower 95% Upper 95% Lower 95.0%Upper 95.0%
Intercept 3.39289809 0.237894561 14.26219 3.73E‐36 2.924885095 3.86091108 2.9248851 3.86091108
X Variable 1 ‐0.010845 0.002781385 ‐3.89914 0.000117 ‐0.01631687 ‐0.0053732 ‐0.0163169 ‐0.0053732  
PDG regression analysis
Cross Country PDG all subjects
SUMMARY OUTPUT
Regression Statistics
Multiple R 0.016676
R Square 0.000278
Adjusted R Square ‐0.00187
Standard Error 1.794396
Observations 468
ANOVA
df SS MS F Significance F
Regression 1 0.417355 0.417355 0.129619 0.718990505
Residual 466 1500.453 3.219856
Total 467 1500.87
Coefficientsandard Err t Stat P‐value Lower 95% Upper 95% Lower 95.0% Upper 95.0%
Intercept 2.195182 0.180322 12.17365 8.54E‐30 1.840836449 2.549527977 1.840836449 2.54952798
X Variable 1 0.000447 0.001243 0.360026 0.718991 ‐0.001994862 0.002889796 ‐0.00199486 0.0028898  
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Cross Country PDG non‐contracepting
SUMMARY OUTPUT
Regression Statistics
Multiple R 0.102811
R Square 0.01057
Adjusted R Square 0.007182
Standard Error 2.115529
Observations 294
ANOVA
df SS MS F Significance F
Regression 1 13.96105 13.96105 3.119467 0.078406924
Residual 292 1306.835 4.475461
Total 293 1320.796
Coefficientsandard Err t Stat P‐value Lower 95% Upper 95% Lower 95.0% Upper 95.0%
Intercept 3.05718 0.271793 11.24819 1.26E‐24 2.522258418 3.592102278 2.522258418 3.59210228
X Variable 1 ‐0.00308 0.001743 ‐1.7662 0.078407 ‐0.006508086 0.000351901 ‐0.00650809 0.0003519
Cross Country PDG contracepting
SUMMARY OUTPUT
Regression Statistics
Multiple R 0.40851
R Square 0.16688
Adjusted R Square 0.162036
Standard Error 0.573529
Observations 174
ANOVA
df SS MS F Significance F
Regression 1 11.33277 11.33277 34.45289 2.19535E‐08
Residual 172 56.57684 0.328935
Total 173 67.90961
Coefficientsandard Err t Stat P‐value Lower 95% Upper 95% Lower 95.0% Upper 95.0%
Intercept 1.099786 0.098178 11.20199 3.2E‐22 0.905997987 1.293574639 0.905997987 1.29357464
X Variable 1 0.004626 0.000788 5.869658 2.2E‐08 0.00307007 0.006181038 0.00307007 0.00618104  
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All non‐contracepting Subjects PDG
SUMMARY OUTPUT
Regression Statistics
Multiple R 0.1111729
R Square 0.01235941
Adjusted R Square 0.00875489
Standard Error 3.14054563
Observations 276
ANOVA
df SS MS F Significance F
Regression 1 33.81891706 33.81892 3.428858 0.065142103
Residual 274 2702.469363 9.863027
Total 275 2736.28828
Coefficients Standard Error t Stat P‐value Lower 95% Upper 95% Lower 95.0%Upper 95.0%
Intercept 3.71385685 0.401382811 9.252655 6.49E‐18 2.923670735 4.50404296 2.92367074 4.50404296
X Variable 1 ‐0.0057173 0.003087542 ‐1.85172 0.065142 ‐0.011795573 0.00036106 ‐0.0117956 0.00036106  
All contracepting Subjects PDG
SUMMARY OUTPUT
Regression Statistics
Multiple R 0.019717
R Square 0.000389
Adjusted R Square ‐0.00268
Standard Error 1.211959
Observations 328
ANOVA
df SS MS F Significance F
Regression 1 0.186224 0.186224 0.126783 0.722021391
Residual 326 478.843 1.468843
Total 327 479.0292
Coefficientsandard Err t Stat P‐value Lower 95% Upper 95% Lower 95.0% Upper 95.0%
Intercept 1.977659 0.127902 15.46234 7.76E‐41 1.726042355 2.229275968 1.726042355 2.22927597
X Variable 1 0.000384 0.001078 0.356066 0.722021 ‐0.001736316 0.002503747 ‐0.00173632 0.00250375  
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All subjects combined PDG
SUMMARY OUTPUT
Regression Statistics
Multiple R 0.21897912
R Square 0.04795186
Adjusted R Square 0.04694011
Standard Error 5.75089693
Observations 943
ANOVA
df SS MS F Significance F
Regression 1 1567.499094 1567.499 47.39539 1.0591E‐11
Residual 941 31121.51939 33.07282
Total 942 32689.01849
Coefficients Standard Error t Stat P‐value Lower 95% Upper 95% Lower 95.0%Upper 95.0%
Intercept 5.66203493 0.357751347 15.82673 3.36E‐50 4.959952156 6.36411771 4.95995216 6.36411771
X Variable 1 ‐0.0205487 0.002984814 ‐6.88443 1.06E‐11 ‐0.026406412 ‐0.0146911 ‐0.0264064 ‐0.0146911  
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One Way ANOVA Testing 
Variable 1 Variable 2
Mean 55071.81969 63755.19526
Variance 344055985.9 424894159.1
Observations 18 18
Pooled Variance 384475072.5
Hypothesized Mean Diffe 0
df 34
t Stat ‐1.328543401
P(T<=t) one‐tail 0.096423629
t Critical one‐tail 1.690924198
P(T<=t) two‐tail 0.192847259
t Critical two‐tail 2.032244498
t‐Test: Two‐Sample Assuming Equal Variances
Non‐Contracepting In‐Season
T‐Test Analysis Sport Difference on E1C
 
Variable 1 Variable 2
Mean 82462.83222 65409.6125
Variance 2035390993 377641469.1
Observations 18 18
Pooled Variance 1206516231
Hypothesized Mean Differe 0
df 34
t Stat 1.472858611
P(T<=t) one‐tail 0.074993543
t Critical one‐tail 1.690924198
P(T<=t) two‐tail 0.149987087
t Critical two‐tail 2.032244498
T‐Test Analysis Sport Difference on E1C
Non‐Contracepting Post‐Season
t‐Test: Two‐Sample Assuming Equal Variances
 
 
 
 
 
Variable 1 Variable 2
Mean 2546.035917 2728.703631
Variance 1305866.474 1820060.741
Observations 17 18
Pooled Variance 1570754.43
Hypothesized Mean Diffe 0
df 33
t Stat ‐0.430957396
P(T<=t) one‐tail 0.334650705
t Critical one‐tail 1.692360258
P(T<=t) two‐tail 0.66930141
t Critical two‐tail 2.034515287
t‐Test: Two‐Sample Assuming Equal Variances
T‐Test Analysis Sport Difference on PDG
Contracepting In‐Season
 
Variable 1 Variable 2
Mean 3943.502783 3398.474449
Variance 17384627 3262349.309
Observations 16 18
Pooled Variance 9882166.977
Hypothesized Mean Differe 0
df 32
t Stat 0.504602935
P(T<=t) one‐tail 0.30864752
t Critical one‐tail 1.693888703
P(T<=t) two‐tail 0.61729504
t Critical two‐tail 2.036933334
T‐Test Analysis Sport Difference on PDG
Contracepting Post‐Season
t‐Test: Two‐Sample Assuming Equal Variances
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Variable 1 Variable 2
Mean 2.845038029 2.416277985
Variance 6.14169334 1.782338455
Observations 69 72
Pooled Variance 3.9149725
Hypothesized Mean Diffe 0
df 139
t Stat 1.286267172
P(T<=t) one‐tail 0.100244101
t Critical one‐tail 1.655889868
P(T<=t) two‐tail 0.200488201
t Critical two‐tail 1.977177694
T‐Test Analysis Sport Difference on E1C
All Subjects Combined In‐Season
t‐Test: Two‐Sample Assuming Equal Variances
 
t‐Test: Two‐Sample Assuming Equal Variances
Variable 1 Variable 2
Mean 54.29637605 47.24897898
Variance 937.7929485 527.8516184
Observations 72 72
Pooled Variance 732.8222835
Hypothesized Mean Differe 0
df 142
t Stat 1.561998666
P(T<=t) one‐tail 0.060257107
t Critical one‐tail 1.655655173
P(T<=t) two‐tail 0.120514213
t Critical two‐tail 1.976810963
T‐Test Analysis Sport Difference on E1C
All Subjects Combined Post‐Season
t‐Test: Two‐Sample Assuming Equal Variances
 
 
 
Variable 1 Variable 2
Mean 2546.035917 2728.703631
Variance 1305866.474 1820060.741
Observations 17 18
Pooled Variance 1570754.43
Hypothesized Mean Diffe 0
df 33
t Stat ‐0.430957396
P(T<=t) one‐tail 0.334650705
t Critical one‐tail 1.692360258
P(T<=t) two‐tail 0.66930141
t Critical two‐tail 2.034515287
T‐Test Analysis Sport Difference on PDG
All Subjects Combined In‐Season
t‐Test: Two‐Sample Assuming Equal Variances
 
Variable 1 Variable 2
Mean 3943.502783 3398.474449
Variance 17384627 3262349.309
Observations 16 18
Pooled Variance 9882166.977
Hypothesized Mean Differe 0
df 32
t Stat 0.504602935
P(T<=t) one‐tail 0.30864752
t Critical one‐tail 1.693888703
P(T<=t) two‐tail 0.61729504
t Critical two‐tail 2.036933334
T‐Test Analysis Sport Difference on PDG
All Subjects Combined In‐Season
t‐Test: Two‐Sample Assuming Equal Variances
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Variable 1 Variable 2
Mean 60925.10937 35186.21182
Variance 328851500.9 40810964.36
Observations 18 18
Pooled Variance 184831232.6
Hypothesized Mean Diffe 0
df 34
t Stat 5.679675401
P(T<=t) one‐tail 1.12292E‐06
t Critical one‐tail 1.690924198
P(T<=t) two‐tail 2.24583E‐06
t Critical two‐tail 2.032244498
Variable 1 Variable 2
Mean 72166.89461 38985.60605
Variance 717595845.9 84311007.53
Observations 19 19
Pooled Variance 400953426.7
Hypothesized Mean Diffe 0
df 36
t Stat 5.10749659
P(T<=t) one‐tail 5.40659E‐06
t Critical one‐tail 1.688297694
P(T<=t) two‐tail 1.08132E‐05
t Critical two‐tail 2.028093987
Variable 1 Variable 2
Mean 66540.90999 37070.74692
Variance 561214430.5 66826373.03
Observations 36 36
Pooled Variance 314020401.8
Hypothesized Mean Diffe 0
df 70
t Stat 7.055695975
P(T<=t) one‐tail 4.94281E‐10
t Critical one‐tail 1.66691448
P(T<=t) two‐tail 9.88562E‐10
t Critical two‐tail 1.994437086
Combined seasons
t‐Test: Two‐Sample Assuming Equal Variances
t‐Test: Two‐Sample Assuming Equal Variances
t‐Test: Two‐Sample Assuming Equal Variances
In season comparison
Post season comparison
T‐Test Analysis contraception vs non‐contraception Difference on E1C
Variable 1 Variable 2
Mean 2837.125169 2230.906941
Variance 2411801.865 479297.111
Observations 18 18
Pooled Variance 1445549.488
Hypothesized Mean Differe 0
df 34
t Stat 1.512633672
P(T<=t) one‐tail 0.069806654
t Critical one‐tail 1.690924198
P(T<=t) two‐tail 0.139613307
t Critical two‐tail 2.032244498
Variable 1 Variable 2
Mean 3651.903255 1992.94753
Variance 6285216.34 181736.9925
Observations 18 18
Pooled Variance 3233476.666
Hypothesized Mean Differe 0
df 34
t Stat 2.767713834
P(T<=t) one‐tail 0.004534394
t Critical one‐tail 1.690924198
P(T<=t) two‐tail 0.009068789
t Critical two‐tail 2.032244498
Combined seasons
Variable 1 Variable 2
Mean 3244.514212 2111.927235
Variance 4394973.698 335634.3397
Observations 36 36
Pooled Variance 2365304.019
Hypothesized Mean Differe 0
df 70
t Stat 3.124383468
P(T<=t) one‐tail 0.001296271
t Critical one‐tail 1.66691448
P(T<=t) two‐tail 0.002592541
t Critical two‐tail 1.994437086
t‐Test: Two‐Sample Assuming Equal Variances
Post season
t‐Test: Two‐Sample Assuming Equal Variances
t‐Test: Two‐Sample Assuming Equal Variances
In season
T‐Test Analysis contraception vs non‐contraception Difference on 
PDG
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Two-Way ANOVA Testing 
Variable 1Variable 2 Variable 1 Variable 2
Mean 60925.11 72156.71 Mean 35186.21182 38955.28
Variance 3.29E+08 7.6E+08 Variance 40810964.36 89251979
Observations 18 18 Observations 18 18
Pearson Correlation 0.781156 Pearson Correlation 0.495232
Hypothesized Mean  0 Hypothesized Mean  0
df 17 df 17
t Stat ‐2.71646 t Stat ‐1.907379459
P(T<=t) one‐tail 0.007331 P(T<=t) one‐tail 0.036756211
t Critical one‐tail 1.739607 t Critical one‐tail 1.739606716
P(T<=t) two‐tail 0.014662 P(T<=t) two‐tail 0.073512422
t Critical two‐tail 2.109816 t Critical two‐tail 2.109815559
Variable 1Variable 2 Variable 1 Variable 2
Mean 2837.125 3651.903 Mean 2230.906941 1992.948
Variance 2411802 6285216 Variance 479297.111 181737
Observations 18 18 Observations 18
Pearson Correlation 0.925143 Pearson Correlation 0.64917
Hypothesized Mean  0 Hypothesized Mean Diff 0
df 17 df 17
t Stat ‐2.82901 t Stat 1.91530185
P(T<=t) one‐tail 0.005788 P(T<=t) one‐tail 0.036216035
t Critical one‐tail 1.739607 t Critical one‐tail 1.739606716
P(T<=t) two‐tail 0.011576 P(T<=t) two‐tail 0.072432069
t Critical two‐tail 2.109816 t Critical two‐tail 2.109816
t‐Test: Paired Two Sample for Means
Two‐way ANOVA reapeated for Menstrual Day and 
Season
E1C contracepting Athletes
t‐Test: Paired Two Sample for Means
Two‐way ANOVA reapeated for Menstrual Day and 
Season
PDG contracepting Athletes
t‐Test: Paired Two Sample for Means
Two‐way ANOVA reapeated for Menstrual Day and 
Season
PDG non‐contracepting Athletes
E1C non‐contracepting Athletes
t‐Test: Paired Two Sample for Means
Two‐way ANOVA reapeated for Menstrual Day and 
Season
 
 
 
 
 
 
 
 
 
 
 
 
126 
 
Time Bin Analysis with Averaged Day Hormonal Levels 
 
(IS)  67211.0033333333 46374.3 39395.8 32067.54 48240.05 61114.81 (IS)  45914.9166666667 34507.18 26440.41 18103 25318.19 37544.25
(OS)    61103.2614285714 50521.08 69816.87 37968.02 45533.51 40679.4 (OS) 66932.2633333333 41438.84 27520.13 22762.84 18220.63 38993.61
t‐Test: Paired Two Sample for Means t‐Test: Paired Two Sample for Means
Variable 1Variable 2 Variable 1Variable 2
Mean 49067.25 50937.02 Mean 31304.66 35978.05
Variance 1.73E+08 1.53E+08 Variance 99286180 3.12E+08
Observations 6 6 Observations 6 6
Pearson Correlation 0.128481 Pearson Correlation 0.921379
Hypothesized Mean Diff 0 Hypothesized Mean Dif 0
df 5 df 5
t Stat ‐0.2719 t Stat ‐1.22858
P(T<=t) one‐tail 0.398286 P(T<=t) one‐tail 0.136948
t Critical one‐tail 2.015048 t Critical one‐tail 2.015048
P(T<=t) two‐tail 0.796572 P(T<=t) two‐tail 0.273897
t Critical two‐tail 2.570582 t Critical two‐tail 2.570582
(IS)                    134862.12 60153.41 103268.1 43189.51 67517.86 89072.74 (IS)       71922.71125 29499.18 22510.78 21924.15 26696.92 42743.82
(OS)                  114854.33 116034.4 85018.87 51438.57 86181.18 84242.68 (OS)      130059.1525 55654.12 31663.35 14720.1 61495.04 53036.98
t‐Test: Paired Two Sample for Means t‐Test: Paired Two Sample for Means
Variable 1Variable 2 Variable 1Variable 2
Mean 83010.63 89628.35 Mean 35882.93 57771.46
Variance 1.1E+09 5.71E+08 Variance 3.69E+08 1.56E+09
Observations 6 6 Observations 6 6
Pearson Correlation 0.544089 Pearson Correlation 0.923168
Hypothesized Mean Diff 0 Hypothesized Mean Dif 0
df 5 df 5
t Stat ‐0.57076 t Stat ‐2.33253
P(T<=t) one‐tail 0.296427 P(T<=t) one‐tail 0.0335
t Critical one‐tail 2.015048 t Critical one‐tail 2.015048
P(T<=t) two‐tail 0.592854 P(T<=t) two‐tail 0.067
t Critical two‐tail 2.570582 t Critical two‐tail 2.570582
(IS)      122912.823333333 45665.81 113015.3 74941.94 70394.6 86868.31 (IS)      51796.4883333333 29889.66 29144.69 24863.69 24238.1 50087.58
(OS)                93843.36625 95233 84018.49 75552.25 88472.41 80977.25 (OS)             70242.23 31756.3 36149.96 19907.88 69698.42 50639.54
t‐Test: Paired Two Sample for Means t‐Test: Paired Two Sample for Means
Variable 1Variable 2 Variable 1Variable 2
Mean 85633.14 86349.46 Mean 35003.37 46399.06
Variance 8.17E+08 58091296 Variance 1.58E+08 4.3E+08
Observations 6 6 Observations 6 6
Pearson Correlation ‐0.05789 Pearson Correlation 0.473807
Hypothesized Mean Diff 0 Hypothesized Mean Dif 0
df 5 df 5
t Stat ‐0.05848 t Stat ‐1.51155
P(T<=t) one‐tail 0.477817 P(T<=t) one‐tail 0.095524
t Critical one‐tail 2.015048 t Critical one‐tail 2.015048
P(T<=t) two‐tail 0.955634 P(T<=t) two‐tail 0.191049
t Critical two‐tail 2.570582 t Critical two‐tail 2.570582
 Average of Subjects  E1C mg/mL per day
Contracepting Athletes E1C Bin Analysis In‐Season vs             
Off‐Season
time bin 1 menstrual days 2‐9 (OS)
Average of Subjects  E1C mg/mL per day
 Contracepting Athletes E1C Bin Analysis In‐Season vs           Off‐
Season
time bin 2 menstrual days 12‐19 (OS)
Average of Subjects  E1C mg/mL per day
Contracepting Athletes E1C Bin Analysis In‐Season vs             
Off‐Season
time bin 3 menstrual days 22‐28 (OS)
Average of Subjects  E1C mg/mL per day
Non Contracepting Athletes E1C Bin Analysis In‐Season vs         
Off‐Season
time bin 2 menstrual days 12‐19 (IS)
 Average of Subjects  E1C mg/mL per day
Non Contracepting Athletes E1C Bin Analysis In‐Season vs         
Off‐Season
time bin 3 menstrual days 22‐28 (IS)
Non Contracepting Athletes E1C Bin Analysis In‐Season vs         
Off‐Season
time bin 1 menstrual days 2‐9 (IS)
 Average of Subjects  E1C mg/mL per day
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67211.00333 46374.3 39395.8 32067.54 48240.05 61114.81 61103.26143 50521.08 69816.87 37968.02 45533.51 40679.4
45914.91667 34507.18 26440.41 18103 25318.19 37544.25 66932.26333 41438.84 27520.13 22762.84 18220.63 38993.61
t‐Test: Paired Two Sample for Means t‐Test: Paired Two Sample for Means
Variable 1Variable 2 Variable 1Variable 2
Mean 49067.25 31304.66 Mean 50937.02 35978.05
Variance 1.73E+08 99286180 Variance 1.53E+08 3.12E+08
Observations 6 6 Observations 6 6
Pearson Correlation 0.928012 Pearson Correlation 0.356942
Hypothesized Mean Diff 0 Hypothesized Mean Dif 0
df 5 df 5
t Stat 8.075938 t Stat 2.085909
P(T<=t) one‐tail 0.000236 P(T<=t) one‐tail 0.045687
t Critical one‐tail 2.015048 t Critical one‐tail 2.015048
P(T<=t) two‐tail 0.000472 P(T<=t) two‐tail 0.091373
t Critical two‐tail 2.570582 t Critical two‐tail 2.570582
134862.12 60153.41 103268.1 43189.51 67517.86 89072.74 114854.33 116034.4 85018.87 51438.57 86181.18 84242.68
71922.71125 29499.18 22510.78 21924.15 26696.92 42743.82 130059.1525 55654.12 31663.35 14720.1 61495.04 53036.98
t‐Test: Paired Two Sample for Means t‐Test: Paired Two Sample for Means
Variable 1Variable 2 Variable 1Variable 2
Mean 83010.63 35882.93 Mean 89628.35 57771.46
Variance 1.1E+09 3.69E+08 Variance 5.71E+08 1.56E+09
Observations 6 6 Observations 6 6
Pearson Correlation 0.780826 Pearson Correlation 0.751202
Hypothesized Mean Diff 0 Hypothesized Mean Dif 0
df 5 df 5
t Stat 5.311688 t Stat 2.921929
P(T<=t) one‐tail 0.001581 P(T<=t) one‐tail 0.01647
t Critical one‐tail 2.015048 t Critical one‐tail 2.015048
P(T<=t) two‐tail 0.003162 P(T<=t) two‐tail 0.03294
t Critical two‐tail 2.570582 t Critical two‐tail 2.570582
122912.8233 45665.81 113015.3 74941.94 70394.6 86868.31 93843.36625 95233 84018.49 75552.25 88472.41 80977.25
51796.48833 29889.66 29144.69 24863.69 24238.1 50087.58 70242.23 31756.3 36149.96 19907.88 69698.42 50639.54
t‐Test: Paired Two Sample for Means t‐Test: Paired Two Sample for Means
Variable 1Variable 2 Variable 1Variable 2
Mean 85633.14 35003.37 Mean 86349.46 46399.06
Variance 8.17E+08 1.58E+08 Variance 58091296 4.3E+08
Observations 6 6 Observations 6 6
Pearson Correlation 0.535432 Pearson Correlation 0.487384
Hypothesized Mean Diff 0 Hypothesized Mean Dif 0
df 5 df 5
t Stat 5.10437 t Stat 5.353553
P(T<=t) one‐tail 0.001878 P(T<=t) one‐tail 0.001528
t Critical one‐tail 2.015048 t Critical one‐tail 2.015048
P(T<=t) two‐tail 0.003756 P(T<=t) two‐tail 0.003055
t Critical two‐tail 2.570582 t Critical two‐tail 2.570582
 Average of Subjects  E1C mg/mL per day
Non Contracepting vs Contracepting Athletes E1C Bin Analysis 
time bin 1 menstrual days 12‐19 (OS)
Average of Subjects  E1C mg/mL per day
Non Contracepting vs Contracepting Athletes E1C Bin Analysis 
time bin 1 menstrual days 22‐28 (OS)
Average of Subjects  E1C mg/mL per day
Non Contracepting vs Contracepting Athletes E1C Bin Analysis     
time bin 2 menstrual days 12‐19 (IS)
 Average of Subjects  E1C mg/mL per day
Non Contracepting vs Contracepting Athletes E1C Bin Analysis     
time bin 3 menstrual days 22‐28 (IS)
Non Contracepting vs Contracepting Athletes E1C Bin Analysis     
In‐Season Values
time bin 1 menstrual days 2‐9 (IS)
Non Contracepting vs Contracepting Athletes E1C Bin Analysis 
Off‐Season Values
time bin 1 menstrual days 2‐9 (OS)
 Average of Subjects  E1C mg/mL per day Average of Subjects  E1C mg/mL per day
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1404.339 1834.81 2214.819 2032.963 2067.508 2756.457 1245.434 525.5901 2353.266 1061.258 2794.232
3832.391613 1385.16 1563.138 2865.179 1434.873 2075.053 2853.525 2304.758 1789.652 2480.917 867.5165 2204.702
t‐Test: Paired Two Sample for Means t‐Test: Paired Two Sample for Means
Variable 1Variable 2 Variable 1Variable 2
Mean 1910.888 1864.681 Mean 1789.373 2083.512
Variance 98546.41 387713.9 Variance 937227.5 475897.5
Observations 5 5 Observatio 6 6
Pearson Correlati #N/A Pearson C 0.666903
Hypothesized Me 0 Hypothesi 0
df 4 df 5
t Stat 0.073617 t Stat ‐0.9969
P(T<=t) one‐tail 0.472425 P(T<=t) on 0.182291
t Critical one‐tail 2.131847 t Critical o 2.015048
P(T<=t) two‐tail 0.94485 P(T<=t) tw 0.364583
t Critical two‐tail 2.776445 t Critical tw2.570582
1865.894 2758.745 3196.993 1259.558 1453.143 1365.742 693.0963 1753.73 1543.543 3001.022
2044.23 4494.043 2970.797 2332.811 2457.661 1395.286 1269.506 1793.133 1702.312 2802.742
t‐Test: Paired Two Sample for Means t‐Test: Paired Two Sample for Means
Variable 1Variable 2 Variable 1Variable 2
Mean 2106.867 2859.908 Mean 1671.427 1792.596
Variance 704168.8 946914.5 Variance 710381.3 365006.3
Observations 5 5 Observatio 5 5
Pearson Correlati 0.640566 Pearson C 0.975966
Hypothesized Me 0 Hypothesi 0
df 4 df 4
t Stat ‐2.16493 t Stat ‐0.94938
P(T<=t) one‐tail 0.048178 P(T<=t) on 0.198093
t Critical one‐tail 2.131847 t Critical o 2.131847
P(T<=t) two‐tail 0.096355 P(T<=t) tw 0.396186
t Critical two‐tail 2.776445 t Critical tw2.776445
26683.93158 4897.709 9788.525 2453.202 1701.196 6222.863 4418.791 1178.717 1228.253 2930.673 1478.17 3297.495
10417.66434 5189.71 6877.007 2912.186 2677.746 8366.567 3860.3 2154.459 1660.008 2017.87 1619.835 2275.635
t‐Test: Paired Two Sample for Means t‐Test: Paired Two Sample for Means
Variable 1Variable 2 Variable 1Variable 2
Mean 8624.571 6073.48 Mean 2422.017 2264.684
Variance 86634383 9416336 Variance 1774803 680127.8
Observations 6 6 Observatio 6 6
Pearson Correlati 0.841643 Pearson C 0.82602
Hypothesized Me 0 Hypothesi 0
df 5 df 5
t Stat 0.902201 t Stat 0.481778
P(T<=t) one‐tail 0.204154 P(T<=t) on 0.325156
t Critical one‐tail 2.015048 t Critical o 2.015048
P(T<=t) two‐tail 0.408307 P(T<=t) tw 0.650311
t Critical two‐tail 2.570582 t Critical tw2.570582
Non Contracepting Athletes PDG Bin Analysis               
time bin 3 menstrual days 22‐28 (IS)
 Average of Subjects  PDG  per day
Non Contracepting Athletes PDG Bin Analysis        
time bin 3 menstrual days 22‐28 (OS)
Average of Subjects  PDG  per day
Non Contracepting Athletes PDG Bin Analysis               
time bin 2 menstrual days 12‐19 (IS)
 Average of Subjects  PDG  per day
Contracepting Athletes PDG Bin Analysis            
time bin 2 menstrual days 12‐19 (OS)
Average of Subjects  PDG  per day
Non Contracepting Athletes PDG Bin Analysis               
In‐Season vs  Off‐Season
time bin 1 menstrual days 2‐9 (IS)
 Average of Subjects  PDG  per day
Contracepting Athletes E1C Bin Analysis In‐Season 
vs                       Off‐Season
time bin 1 menstrual days 2‐9 (OS)
Average of Subjects  PDG  per day
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1404.339 1834.81 2214.819 2032.963 2067.508 3832.392 1385.16 1563.138 2865.179 1434.873 2075.053
1245.434 525.5901 2353.266 1061.258 2794.232 2853.525 2304.758 1789.652 2480.917 867.5165 2204.702
t‐Test: Paired Two Sample for Means t‐Test: Paired Two Sample for Means
Variable 1Variable 2 Variable 1Variable 2
Mean 1910.888 1595.956 Mean 2192.632 2083.512
Variance 98546.41 890958.6 Variance 955485.6 475897.5
Observations 5 5 Observatio 6 6
Pearson Correlati 0.515975 Pearson C 0.724703
Hypothesized Me 0 Hypothesi 0
df 4 df 5
t Stat 0.851649 t Stat 0.396687
P(T<=t) one‐tail 0.221197 P(T<=t) on 0.353982
t Critical one‐tail 2.131847 t Critical o 2.015048
P(T<=t) two‐tail 0.442393 P(T<=t) tw 0.707963
t Critical two‐tail 2.776445 t Critical tw2.570582
5292.186 1865.894 2758.745 3196.993 1259.558 1453.143 2044.23 4494.043 2970.797 2332.811 2457.661
4733.191213 1365.742 693.0963 1753.73 1543.543 3001.022 1395.286 1269.506 1793.133 1702.312 2802.742
t‐Test: Paired Two Sample for Means t‐Test: Paired Two Sample for Means
Variable 1Variable 2 Variable 1Variable 2
Mean 2637.753 2181.721 Mean 2859.908 1792.596
Variance 2254378 2130705 Variance 946914.5 365006.3
Observations 6 6 Observatio 5 5
Pearson Correlati 0.628931 Pearson C ‐0.37821
Hypothesized Me 0 Hypothesi 0
df 5 df 4
t Stat 0.875405 t Stat 1.800683
P(T<=t) one‐tail 0.210704 P(T<=t) on 0.073061
t Critical one‐tail 2.015048 t Critical o 2.131847
P(T<=t) two‐tail 0.421409 P(T<=t) tw 0.146122
t Critical two‐tail 2.570582 t Critical tw2.776445
26683.93158 4897.709 9788.525 2453.202 1701.196 6222.863 10417.66 5189.71 6877.007 2912.186 2677.746 8366.567
4418.791267 1178.717 1228.253 2930.673 1478.17 3297.495 3860.3 2154.459 1660.008 2017.87 1619.835 2275.635
t‐Test: Paired Two Sample for Means t‐Test: Paired Two Sample for Means
Variable 1Variable 2 Variable 1Variable 2
Mean 8624.571 2422.017 Mean 6073.48 2264.684
Variance 86634383 1774803 Variance 9416336 680127.8
Observations 6 6 Observatio 6 6
Pearson Correlati 0.6548 Pearson C 0.753814
Hypothesized Me 0 Hypothesi 0
df 5 df 5
t Stat 1.788411 t Stat 3.722577
P(T<=t) one‐tail 0.066869 P(T<=t) on 0.006838
t Critical one‐tail 2.015048 t Critical o 2.015048
P(T<=t) two‐tail 0.133738 P(T<=t) tw 0.013676
t Critical two‐tail 2.570582 t Critical tw2.570582
Non Contracepting vs Contracepting Athletes PDG Bin 
time bin 1 menstrual days 22‐28 (IS)
 Average of Subjects PDG  per day
Non Contracepting vs Contracepting Athletes PDG 
time bin 1 menstrual days 22‐28 (IS)
Average of Subjects PDG  per day
Non Contracepting vs Contracepting Athletes PDG Bin 
time bin 1 menstrual days 12‐19 (IS)
 Average of Subjects PDG  per day
Non Contracepting vs Contracepting Athletes PDG 
time bin 1 menstrual days 12‐19 (OS)
Average of Subjects PDG  per day
Non Contracepting vs Contracepting Athletes PDG Bin 
time bin 1 menstrual days 2‐9 (IS)
 Average of Subjects PDG  per day
Non Contracepting vs Contracepting Athletes PDG 
time bin 1 menstrual days 2‐9 (OS)
Average of Subjects  PDG per day
 
 
